2D miR_HR1_12
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Sp1
|
ENSMUSG00000001280.6 | trans-acting transcription factor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Sp1 | mm10_v2_chr15_+_102407144_102407269 | -0.84 | 6.4e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_+_29170204 | 8.64 |
ENSMUST00000098609.2
|
Ggn
|
gametogenetin |
chr19_-_10457447 | 8.27 |
ENSMUST00000171400.2
|
Lrrc10b
|
leucine rich repeat containing 10B |
chr15_-_75566608 | 7.47 |
ENSMUST00000163116.1
ENSMUST00000023241.5 |
Ly6h
|
lymphocyte antigen 6 complex, locus H |
chr4_+_43046014 | 7.33 |
ENSMUST00000180426.1
|
Gm26881
|
predicted gene, 26881 |
chr4_-_43045686 | 7.28 |
ENSMUST00000107956.1
ENSMUST00000107957.1 |
Fam214b
|
family with sequence similarity 214, member B |
chr4_-_43046196 | 7.07 |
ENSMUST00000036462.5
|
Fam214b
|
family with sequence similarity 214, member B |
chr7_+_29170345 | 6.79 |
ENSMUST00000033886.7
|
Ggn
|
gametogenetin |
chr12_+_24651346 | 6.66 |
ENSMUST00000020982.5
|
Klf11
|
Kruppel-like factor 11 |
chr17_+_26933070 | 6.65 |
ENSMUST00000073724.5
|
Phf1
|
PHD finger protein 1 |
chr15_-_32244632 | 6.40 |
ENSMUST00000181536.1
|
0610007N19Rik
|
RIKEN cDNA 0610007N19 |
chr15_-_75566811 | 6.29 |
ENSMUST00000065417.8
|
Ly6h
|
lymphocyte antigen 6 complex, locus H |
chr4_+_120854786 | 6.25 |
ENSMUST00000071093.2
|
Rims3
|
regulating synaptic membrane exocytosis 3 |
chr9_+_59578192 | 5.91 |
ENSMUST00000118549.1
ENSMUST00000034840.3 |
Celf6
|
CUGBP, Elav-like family member 6 |
chr7_-_128237984 | 5.90 |
ENSMUST00000078816.3
|
9130023H24Rik
|
RIKEN cDNA 9130023H24 gene |
chr10_+_80167778 | 5.71 |
ENSMUST00000105365.2
ENSMUST00000054666.6 |
Cirbp
|
cold inducible RNA binding protein |
chr11_-_102296618 | 5.52 |
ENSMUST00000107132.2
ENSMUST00000073234.2 |
Atxn7l3
|
ataxin 7-like 3 |
chr7_+_49975228 | 5.50 |
ENSMUST00000107603.1
|
Nell1
|
NEL-like 1 |
chr17_+_72836678 | 5.36 |
ENSMUST00000045174.5
|
Ypel5
|
yippee-like 5 (Drosophila) |
chr7_+_121865070 | 5.29 |
ENSMUST00000033161.5
|
Scnn1b
|
sodium channel, nonvoltage-gated 1 beta |
chr13_+_54789500 | 5.15 |
ENSMUST00000163915.1
ENSMUST00000099503.3 ENSMUST00000171859.1 |
Tspan17
|
tetraspanin 17 |
chr15_-_76521902 | 4.99 |
ENSMUST00000164703.1
ENSMUST00000096365.3 |
Scrt1
|
scratch homolog 1, zinc finger protein (Drosophila) |
chr12_+_108334341 | 4.94 |
ENSMUST00000021684.4
|
Cyp46a1
|
cytochrome P450, family 46, subfamily a, polypeptide 1 |
chr16_+_20733104 | 4.93 |
ENSMUST00000115423.1
ENSMUST00000007171.6 |
Chrd
|
chordin |
chr7_-_143460989 | 4.88 |
ENSMUST00000167912.1
ENSMUST00000037287.6 |
Cdkn1c
|
cyclin-dependent kinase inhibitor 1C (P57) |
chr1_-_184033998 | 4.79 |
ENSMUST00000050306.5
|
1700056E22Rik
|
RIKEN cDNA 1700056E22 gene |
chr8_-_84067283 | 4.69 |
ENSMUST00000071067.3
|
C330011M18Rik
|
RIKEN cDNA C330011M18 gene |
chr17_-_25256274 | 4.64 |
ENSMUST00000182435.1
ENSMUST00000169109.2 ENSMUST00000182056.1 |
Baiap3
|
BAI1-associated protein 3 |
chr17_+_24488773 | 4.60 |
ENSMUST00000024958.7
|
Caskin1
|
CASK interacting protein 1 |
chr2_+_70562007 | 4.60 |
ENSMUST00000094934.4
|
Gad1
|
glutamate decarboxylase 1 |
chr13_-_71963713 | 4.55 |
ENSMUST00000077337.8
|
Irx1
|
Iroquois related homeobox 1 (Drosophila) |
chr15_-_75747922 | 4.55 |
ENSMUST00000062002.4
|
Mafa
|
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein A (avian) |
chr3_-_8667033 | 4.40 |
ENSMUST00000042412.3
|
Hey1
|
hairy/enhancer-of-split related with YRPW motif 1 |
chr19_+_6341121 | 4.37 |
ENSMUST00000025897.6
ENSMUST00000130382.1 |
Map4k2
|
mitogen-activated protein kinase kinase kinase kinase 2 |
chr2_+_172345565 | 4.35 |
ENSMUST00000028995.4
|
Fam210b
|
family with sequence similarity 210, member B |
chr3_+_89418443 | 4.29 |
ENSMUST00000039110.5
ENSMUST00000125036.1 ENSMUST00000154791.1 ENSMUST00000128238.1 ENSMUST00000107417.2 |
Shc1
|
src homology 2 domain-containing transforming protein C1 |
chr9_+_109931774 | 4.29 |
ENSMUST00000169851.2
|
Map4
|
microtubule-associated protein 4 |
chr12_-_4841583 | 4.25 |
ENSMUST00000020964.5
|
Fkbp1b
|
FK506 binding protein 1b |
chr16_-_22439719 | 4.24 |
ENSMUST00000079601.6
|
Etv5
|
ets variant gene 5 |
chr13_+_56522449 | 4.16 |
ENSMUST00000121095.1
ENSMUST00000121871.1 |
Fbxl21
|
F-box and leucine-rich repeat protein 21 |
chr7_-_44816586 | 4.14 |
ENSMUST00000047356.8
|
Atf5
|
activating transcription factor 5 |
chr2_+_174760619 | 4.13 |
ENSMUST00000029030.2
|
Edn3
|
endothelin 3 |
chr1_-_74885322 | 4.08 |
ENSMUST00000159232.1
ENSMUST00000068631.3 |
Fev
|
FEV (ETS oncogene family) |
chr18_-_24709348 | 4.06 |
ENSMUST00000067987.1
|
Gm9955
|
predicted gene 9955 |
chr8_-_90908415 | 4.04 |
ENSMUST00000098517.1
|
Gm6658
|
predicted gene 6658 |
chr12_-_84698769 | 4.01 |
ENSMUST00000095550.2
|
Syndig1l
|
synapse differentiation inducing 1 like |
chr13_+_56522497 | 4.00 |
ENSMUST00000045428.6
|
Fbxl21
|
F-box and leucine-rich repeat protein 21 |
chr11_-_94474088 | 4.00 |
ENSMUST00000107786.1
ENSMUST00000107791.1 ENSMUST00000103166.2 ENSMUST00000107792.1 ENSMUST00000100561.3 ENSMUST00000107793.1 ENSMUST00000107788.1 ENSMUST00000107790.1 ENSMUST00000107789.1 ENSMUST00000107785.1 ENSMUST00000021234.8 |
Cacna1g
|
calcium channel, voltage-dependent, T type, alpha 1G subunit |
chr10_+_127290774 | 3.96 |
ENSMUST00000026475.8
ENSMUST00000139091.1 |
Ddit3
|
DNA-damage inducible transcript 3 |
chr17_-_25433775 | 3.95 |
ENSMUST00000159610.1
ENSMUST00000159048.1 ENSMUST00000078496.5 |
Cacna1h
|
calcium channel, voltage-dependent, T type, alpha 1H subunit |
chr16_-_18586959 | 3.90 |
ENSMUST00000009241.5
|
Tbx1
|
T-box 1 |
chr3_+_96670131 | 3.86 |
ENSMUST00000048427.5
|
Ankrd35
|
ankyrin repeat domain 35 |
chr8_-_124663368 | 3.85 |
ENSMUST00000034464.6
|
2310022B05Rik
|
RIKEN cDNA 2310022B05 gene |
chr3_-_57847478 | 3.84 |
ENSMUST00000120289.1
ENSMUST00000066882.8 |
Pfn2
|
profilin 2 |
chr11_-_107794557 | 3.82 |
ENSMUST00000021066.3
|
Cacng4
|
calcium channel, voltage-dependent, gamma subunit 4 |
chr15_-_100599983 | 3.78 |
ENSMUST00000073837.6
|
Pou6f1
|
POU domain, class 6, transcription factor 1 |
chr7_+_141079759 | 3.78 |
ENSMUST00000066873.4
ENSMUST00000163041.1 |
Pkp3
|
plakophilin 3 |
chr7_+_35334175 | 3.77 |
ENSMUST00000032705.6
ENSMUST00000085556.3 |
Rhpn2
|
rhophilin, Rho GTPase binding protein 2 |
chr2_+_70562147 | 3.76 |
ENSMUST00000148210.1
|
Gad1
|
glutamate decarboxylase 1 |
chr7_+_49974864 | 3.76 |
ENSMUST00000081872.5
ENSMUST00000151721.1 |
Nell1
|
NEL-like 1 |
chr5_+_141241490 | 3.74 |
ENSMUST00000085774.4
|
Sdk1
|
sidekick homolog 1 (chicken) |
chr8_+_105413614 | 3.73 |
ENSMUST00000109355.2
|
Lrrc36
|
leucine rich repeat containing 36 |
chr11_+_78322965 | 3.71 |
ENSMUST00000017534.8
|
Aldoc
|
aldolase C, fructose-bisphosphate |
chr4_-_114908892 | 3.70 |
ENSMUST00000068654.3
|
Foxd2
|
forkhead box D2 |
chrX_-_135009185 | 3.69 |
ENSMUST00000113185.2
ENSMUST00000064659.5 |
Zmat1
|
zinc finger, matrin type 1 |
chr8_+_47675362 | 3.67 |
ENSMUST00000098781.2
|
AA386476
|
expressed sequence AA386476 |
chr5_-_124095749 | 3.66 |
ENSMUST00000031354.4
|
Abcb9
|
ATP-binding cassette, sub-family B (MDR/TAP), member 9 |
chr11_-_109611417 | 3.65 |
ENSMUST00000103060.3
ENSMUST00000047186.3 ENSMUST00000106689.1 |
Wipi1
|
WD repeat domain, phosphoinositide interacting 1 |
chr4_+_108879130 | 3.64 |
ENSMUST00000106651.2
|
Rab3b
|
RAB3B, member RAS oncogene family |
chr5_+_137288273 | 3.64 |
ENSMUST00000024099.4
ENSMUST00000085934.3 |
Ache
|
acetylcholinesterase |
chr7_-_127824469 | 3.61 |
ENSMUST00000106267.3
|
Stx1b
|
syntaxin 1B |
chr5_-_24351604 | 3.60 |
ENSMUST00000036092.7
|
Kcnh2
|
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
chr11_+_114765363 | 3.57 |
ENSMUST00000138804.1
ENSMUST00000084368.5 |
Kif19a
|
kinesin family member 19A |
chr7_+_19359740 | 3.56 |
ENSMUST00000140836.1
|
Ppp1r13l
|
protein phosphatase 1, regulatory (inhibitor) subunit 13 like |
chr4_-_134704235 | 3.56 |
ENSMUST00000054096.6
ENSMUST00000038628.3 |
Man1c1
|
mannosidase, alpha, class 1C, member 1 |
chr1_-_88702121 | 3.55 |
ENSMUST00000159814.1
|
Arl4c
|
ADP-ribosylation factor-like 4C |
chr7_-_19629355 | 3.48 |
ENSMUST00000049912.8
ENSMUST00000094762.3 ENSMUST00000098754.4 |
Relb
|
avian reticuloendotheliosis viral (v-rel) oncogene related B |
chr16_-_22439570 | 3.46 |
ENSMUST00000170393.1
|
Etv5
|
ets variant gene 5 |
chr15_-_75567176 | 3.44 |
ENSMUST00000156032.1
ENSMUST00000127095.1 |
Ly6h
|
lymphocyte antigen 6 complex, locus H |
chr4_-_117872520 | 3.43 |
ENSMUST00000171052.1
ENSMUST00000166325.1 ENSMUST00000106422.2 |
Ccdc24
|
coiled-coil domain containing 24 |
chr4_-_43040279 | 3.43 |
ENSMUST00000107958.1
ENSMUST00000107959.1 ENSMUST00000152846.1 |
Fam214b
|
family with sequence similarity 214, member B |
chr7_-_27396542 | 3.41 |
ENSMUST00000108363.1
|
Sptbn4
|
spectrin beta, non-erythrocytic 4 |
chr4_-_117133953 | 3.40 |
ENSMUST00000076859.5
|
Plk3
|
polo-like kinase 3 |
chr7_+_113207465 | 3.37 |
ENSMUST00000047321.7
|
Arntl
|
aryl hydrocarbon receptor nuclear translocator-like |
chr4_+_108879063 | 3.36 |
ENSMUST00000106650.2
|
Rab3b
|
RAB3B, member RAS oncogene family |
chr4_-_148500449 | 3.35 |
ENSMUST00000030840.3
|
Angptl7
|
angiopoietin-like 7 |
chr16_-_24393588 | 3.35 |
ENSMUST00000181640.1
|
1110054M08Rik
|
RIKEN cDNA 1110054M08 gene |
chr6_-_48445373 | 3.34 |
ENSMUST00000114563.1
ENSMUST00000114558.1 ENSMUST00000101443.3 ENSMUST00000114564.1 |
Zfp467
|
zinc finger protein 467 |
chr17_+_24752980 | 3.34 |
ENSMUST00000044922.6
|
Hs3st6
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 6 |
chr9_+_109931863 | 3.29 |
ENSMUST00000165876.1
|
Map4
|
microtubule-associated protein 4 |
chr11_+_95010277 | 3.28 |
ENSMUST00000124735.1
|
Samd14
|
sterile alpha motif domain containing 14 |
chr8_+_105305572 | 3.25 |
ENSMUST00000109375.2
|
Elmo3
|
engulfment and cell motility 3 |
chr4_+_137277489 | 3.25 |
ENSMUST00000045747.4
|
Wnt4
|
wingless-related MMTV integration site 4 |
chr1_-_134235420 | 3.24 |
ENSMUST00000038191.6
ENSMUST00000086465.4 |
Adora1
|
adenosine A1 receptor |
chr5_+_129941949 | 3.21 |
ENSMUST00000051758.7
ENSMUST00000073945.4 |
Vkorc1l1
|
vitamin K epoxide reductase complex, subunit 1-like 1 |
chr6_-_66896521 | 3.20 |
ENSMUST00000065878.3
|
4930597O21Rik
|
RIKEN cDNA 4930597O21 gene |
chr11_-_69122589 | 3.19 |
ENSMUST00000180487.1
|
9130213A22Rik
|
RIKEN cDNA 9130213A22 gene |
chr13_+_54789377 | 3.18 |
ENSMUST00000026993.7
ENSMUST00000131692.2 ENSMUST00000163796.1 |
Tspan17
|
tetraspanin 17 |
chr7_-_27178835 | 3.17 |
ENSMUST00000093040.6
|
Rab4b
|
RAB4B, member RAS oncogene family |
chr4_+_138454305 | 3.15 |
ENSMUST00000050918.3
|
Camk2n1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
chr8_+_76902277 | 3.15 |
ENSMUST00000109912.1
ENSMUST00000128862.1 ENSMUST00000109911.1 |
Nr3c2
|
nuclear receptor subfamily 3, group C, member 2 |
chr7_-_97332017 | 3.14 |
ENSMUST00000139582.2
|
Usp35
|
ubiquitin specific peptidase 35 |
chr13_-_17694729 | 3.14 |
ENSMUST00000068545.4
|
5033411D12Rik
|
RIKEN cDNA 5033411D12 gene |
chr5_-_138996087 | 3.14 |
ENSMUST00000110897.1
|
Pdgfa
|
platelet derived growth factor, alpha |
chr13_+_12565868 | 3.13 |
ENSMUST00000071973.6
|
Ero1lb
|
ERO1-like beta (S. cerevisiae) |
chr5_+_135168283 | 3.12 |
ENSMUST00000031692.5
|
Bcl7b
|
B cell CLL/lymphoma 7B |
chr4_-_151996113 | 3.09 |
ENSMUST00000055688.9
|
Phf13
|
PHD finger protein 13 |
chr19_+_5425121 | 3.08 |
ENSMUST00000159759.1
|
AI837181
|
expressed sequence AI837181 |
chr19_-_6980420 | 3.07 |
ENSMUST00000070878.8
ENSMUST00000177752.1 |
Fkbp2
|
FK506 binding protein 2 |
chr7_-_100658394 | 3.06 |
ENSMUST00000138830.1
ENSMUST00000107044.3 ENSMUST00000116287.2 |
Plekhb1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
chr11_-_119086221 | 3.06 |
ENSMUST00000026665.7
|
Cbx4
|
chromobox 4 |
chr9_+_114978507 | 3.05 |
ENSMUST00000183104.1
|
Osbpl10
|
oxysterol binding protein-like 10 |
chr11_+_69964758 | 3.04 |
ENSMUST00000108597.1
ENSMUST00000060651.5 ENSMUST00000108596.1 |
Cldn7
|
claudin 7 |
chr2_-_30903255 | 3.04 |
ENSMUST00000102852.3
|
Ptges
|
prostaglandin E synthase |
chr12_+_112678803 | 3.03 |
ENSMUST00000174780.1
ENSMUST00000169593.1 ENSMUST00000173942.1 |
Zbtb42
|
zinc finger and BTB domain containing 42 |
chr6_-_48445678 | 3.03 |
ENSMUST00000114556.1
|
Zfp467
|
zinc finger protein 467 |
chr12_+_17690793 | 3.02 |
ENSMUST00000071858.3
|
Hpcal1
|
hippocalcin-like 1 |
chr9_+_109931458 | 3.00 |
ENSMUST00000072772.5
ENSMUST00000035055.8 |
Map4
|
microtubule-associated protein 4 |
chr9_-_53706211 | 2.98 |
ENSMUST00000068449.3
|
Rab39
|
RAB39, member RAS oncogene family |
chr6_-_48445825 | 2.98 |
ENSMUST00000114561.2
|
Zfp467
|
zinc finger protein 467 |
chr11_-_69605829 | 2.94 |
ENSMUST00000047889.6
|
Atp1b2
|
ATPase, Na+/K+ transporting, beta 2 polypeptide |
chr2_-_92024502 | 2.90 |
ENSMUST00000028663.4
|
Creb3l1
|
cAMP responsive element binding protein 3-like 1 |
chr17_+_46681038 | 2.89 |
ENSMUST00000002845.6
|
Mea1
|
male enhanced antigen 1 |
chr1_+_74854954 | 2.87 |
ENSMUST00000160379.2
|
Cdk5r2
|
cyclin-dependent kinase 5, regulatory subunit 2 (p39) |
chr15_-_76660108 | 2.86 |
ENSMUST00000066677.8
ENSMUST00000177359.1 |
Cyhr1
|
cysteine and histidine rich 1 |
chr14_-_55560340 | 2.86 |
ENSMUST00000066106.3
|
A730061H03Rik
|
RIKEN cDNA A730061H03 gene |
chr2_+_32288244 | 2.84 |
ENSMUST00000113377.1
ENSMUST00000100194.2 |
Golga2
|
golgi autoantigen, golgin subfamily a, 2 |
chr19_+_42255704 | 2.84 |
ENSMUST00000087123.5
|
Golga7b
|
golgi autoantigen, golgin subfamily a, 7B |
chr7_-_30445508 | 2.83 |
ENSMUST00000006828.7
|
Aplp1
|
amyloid beta (A4) precursor-like protein 1 |
chr2_-_128967725 | 2.83 |
ENSMUST00000099385.2
|
Gm10762
|
predicted gene 10762 |
chr4_+_101647763 | 2.83 |
ENSMUST00000106927.1
|
Leprot
|
leptin receptor overlapping transcript |
chr11_+_97799772 | 2.82 |
ENSMUST00000129558.1
|
Lasp1
|
LIM and SH3 protein 1 |
chr12_-_73546383 | 2.80 |
ENSMUST00000042975.5
|
Tmem30b
|
transmembrane protein 30B |
chr1_+_184034381 | 2.80 |
ENSMUST00000048655.7
|
Dusp10
|
dual specificity phosphatase 10 |
chr13_+_48968287 | 2.78 |
ENSMUST00000180775.1
|
Fam120aos
|
family with sequence similarity 120A opposite strand |
chr17_+_35823230 | 2.76 |
ENSMUST00000001569.8
ENSMUST00000174080.1 |
Flot1
|
flotillin 1 |
chr7_-_100658364 | 2.76 |
ENSMUST00000107043.1
|
Plekhb1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
chr3_-_89393294 | 2.76 |
ENSMUST00000142119.1
ENSMUST00000029677.8 ENSMUST00000148361.1 |
Zbtb7b
|
zinc finger and BTB domain containing 7B |
chr4_+_141242850 | 2.76 |
ENSMUST00000138096.1
ENSMUST00000006618.2 ENSMUST00000125392.1 |
Arhgef19
|
Rho guanine nucleotide exchange factor (GEF) 19 |
chr2_-_153529941 | 2.76 |
ENSMUST00000035346.7
|
8430427H17Rik
|
RIKEN cDNA 8430427H17 gene |
chr3_-_89093358 | 2.76 |
ENSMUST00000090929.5
ENSMUST00000052539.6 |
Rusc1
|
RUN and SH3 domain containing 1 |
chr4_+_101647712 | 2.75 |
ENSMUST00000030254.8
|
Leprot
|
leptin receptor overlapping transcript |
chr13_+_72628802 | 2.75 |
ENSMUST00000074372.4
|
Irx2
|
Iroquois related homeobox 2 (Drosophila) |
chr4_+_120666562 | 2.75 |
ENSMUST00000094814.4
|
Cited4
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
chr8_-_90348343 | 2.73 |
ENSMUST00000109621.3
|
Tox3
|
TOX high mobility group box family member 3 |
chr9_-_121792478 | 2.73 |
ENSMUST00000035110.4
|
Hhatl
|
hedgehog acyltransferase-like |
chr4_-_129239165 | 2.73 |
ENSMUST00000097873.3
|
C77080
|
expressed sequence C77080 |
chr7_-_140082489 | 2.69 |
ENSMUST00000026541.7
|
Caly
|
calcyon neuron-specific vesicular protein |
chr13_-_49215978 | 2.69 |
ENSMUST00000048946.6
|
1110007C09Rik
|
RIKEN cDNA 1110007C09 gene |
chr5_+_117357274 | 2.67 |
ENSMUST00000031309.9
|
Wsb2
|
WD repeat and SOCS box-containing 2 |
chr2_+_78869009 | 2.66 |
ENSMUST00000028398.7
|
Ube2e3
|
ubiquitin-conjugating enzyme E2E 3 |
chr17_+_37046555 | 2.65 |
ENSMUST00000172789.1
|
Gabbr1
|
gamma-aminobutyric acid (GABA) B receptor, 1 |
chr1_+_125561010 | 2.64 |
ENSMUST00000027580.4
|
Slc35f5
|
solute carrier family 35, member F5 |
chr6_-_100287441 | 2.64 |
ENSMUST00000101118.2
|
Rybp
|
RING1 and YY1 binding protein |
chr2_-_144332146 | 2.62 |
ENSMUST00000037423.3
|
Ovol2
|
ovo-like 2 (Drosophila) |
chr17_-_26939464 | 2.62 |
ENSMUST00000025027.8
ENSMUST00000114935.1 |
Cuta
|
cutA divalent cation tolerance homolog (E. coli) |
chr1_-_168431896 | 2.60 |
ENSMUST00000176540.1
|
Pbx1
|
pre B cell leukemia homeobox 1 |
chr5_+_108694222 | 2.60 |
ENSMUST00000013633.8
ENSMUST00000112560.3 |
Fgfrl1
|
fibroblast growth factor receptor-like 1 |
chr5_-_100159261 | 2.60 |
ENSMUST00000139520.1
|
Tmem150c
|
transmembrane protein 150C |
chrX_+_142681398 | 2.59 |
ENSMUST00000112889.1
ENSMUST00000101198.2 ENSMUST00000112891.1 ENSMUST00000087333.2 |
Tmem164
|
transmembrane protein 164 |
chr11_+_104132841 | 2.57 |
ENSMUST00000093925.4
|
Crhr1
|
corticotropin releasing hormone receptor 1 |
chr7_-_27333602 | 2.57 |
ENSMUST00000118583.1
ENSMUST00000118961.1 ENSMUST00000121175.1 |
Ltbp4
|
latent transforming growth factor beta binding protein 4 |
chr8_-_35826435 | 2.56 |
ENSMUST00000060128.5
|
Cldn23
|
claudin 23 |
chr7_-_31051431 | 2.54 |
ENSMUST00000073892.4
|
Fxyd7
|
FXYD domain-containing ion transport regulator 7 |
chr19_+_55741810 | 2.54 |
ENSMUST00000111657.3
ENSMUST00000061496.9 ENSMUST00000041717.7 ENSMUST00000111662.4 |
Tcf7l2
|
transcription factor 7 like 2, T cell specific, HMG box |
chr7_-_140082246 | 2.53 |
ENSMUST00000166758.2
|
Caly
|
calcyon neuron-specific vesicular protein |
chr2_-_37359235 | 2.53 |
ENSMUST00000112940.1
|
Pdcl
|
phosducin-like |
chr8_+_84415348 | 2.51 |
ENSMUST00000121390.1
ENSMUST00000122053.1 |
Cacna1a
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
chr2_+_155381808 | 2.51 |
ENSMUST00000043237.7
ENSMUST00000174685.1 |
Trp53inp2
|
transformation related protein 53 inducible nuclear protein 2 |
chr11_+_95009852 | 2.50 |
ENSMUST00000055947.3
|
Samd14
|
sterile alpha motif domain containing 14 |
chr5_-_109558957 | 2.50 |
ENSMUST00000044579.7
|
Crlf2
|
cytokine receptor-like factor 2 |
chr9_-_121759788 | 2.49 |
ENSMUST00000181325.1
|
E530011L22Rik
|
RIKEN cDNA E530011L22 gene |
chr17_+_57249450 | 2.49 |
ENSMUST00000019631.9
|
Trip10
|
thyroid hormone receptor interactor 10 |
chr12_-_32953772 | 2.47 |
ENSMUST00000180391.1
ENSMUST00000181670.1 |
4933406C10Rik
|
RIKEN cDNA 4933406C10 gene |
chrX_-_7574120 | 2.47 |
ENSMUST00000045924.7
ENSMUST00000115742.2 ENSMUST00000150787.1 |
Ppp1r3f
|
protein phosphatase 1, regulatory (inhibitor) subunit 3F |
chr12_-_79007276 | 2.47 |
ENSMUST00000056660.6
ENSMUST00000174721.1 |
Tmem229b
|
transmembrane protein 229B |
chr5_+_30588078 | 2.45 |
ENSMUST00000066295.2
|
Kcnk3
|
potassium channel, subfamily K, member 3 |
chr8_-_90348126 | 2.44 |
ENSMUST00000176034.1
ENSMUST00000176616.1 |
Tox3
|
TOX high mobility group box family member 3 |
chr2_+_32288317 | 2.44 |
ENSMUST00000131712.1
ENSMUST00000133113.1 ENSMUST00000081670.6 ENSMUST00000147707.1 ENSMUST00000129193.1 |
Golga2
|
golgi autoantigen, golgin subfamily a, 2 |
chr11_-_106160101 | 2.44 |
ENSMUST00000045923.3
|
Limd2
|
LIM domain containing 2 |
chr17_+_37045980 | 2.44 |
ENSMUST00000174456.1
|
Gabbr1
|
gamma-aminobutyric acid (GABA) B receptor, 1 |
chr2_+_174760781 | 2.43 |
ENSMUST00000140908.1
|
Edn3
|
endothelin 3 |
chr19_+_4510472 | 2.43 |
ENSMUST00000068004.6
|
Pcx
|
pyruvate carboxylase |
chr3_+_96181151 | 2.42 |
ENSMUST00000035371.8
|
Sv2a
|
synaptic vesicle glycoprotein 2 a |
chr11_+_29692937 | 2.41 |
ENSMUST00000102843.3
ENSMUST00000102842.3 ENSMUST00000078830.4 ENSMUST00000170731.1 |
Rtn4
|
reticulon 4 |
chr11_+_43528759 | 2.40 |
ENSMUST00000050574.6
|
Ccnjl
|
cyclin J-like |
chr18_+_65800543 | 2.40 |
ENSMUST00000025394.6
ENSMUST00000153193.1 |
Sec11c
|
SEC11 homolog C (S. cerevisiae) |
chr7_+_4119556 | 2.40 |
ENSMUST00000079415.5
|
Ttyh1
|
tweety homolog 1 (Drosophila) |
chr17_-_35979679 | 2.39 |
ENSMUST00000173724.1
ENSMUST00000172900.1 ENSMUST00000174849.1 |
Prr3
|
proline-rich polypeptide 3 |
chr2_+_173659760 | 2.38 |
ENSMUST00000029024.3
|
Rab22a
|
RAB22A, member RAS oncogene family |
chr17_+_84957993 | 2.38 |
ENSMUST00000080217.6
ENSMUST00000112304.2 |
Ppm1b
|
protein phosphatase 1B, magnesium dependent, beta isoform |
chr4_+_46039202 | 2.37 |
ENSMUST00000156200.1
|
Tmod1
|
tropomodulin 1 |
chr11_+_61022560 | 2.37 |
ENSMUST00000089184.4
|
Kcnj12
|
potassium inwardly-rectifying channel, subfamily J, member 12 |
chr10_-_80139347 | 2.37 |
ENSMUST00000105369.1
|
Dos
|
downstream of Stk11 |
chr1_-_84696182 | 2.37 |
ENSMUST00000049126.6
|
Dner
|
delta/notch-like EGF-related receptor |
chr17_-_46680870 | 2.37 |
ENSMUST00000165007.1
ENSMUST00000071841.5 |
Klhdc3
|
kelch domain containing 3 |
chr6_+_49367739 | 2.36 |
ENSMUST00000060561.8
ENSMUST00000121903.1 ENSMUST00000134786.1 |
Fam221a
|
family with sequence similarity 221, member A |
chr12_+_36157124 | 2.36 |
ENSMUST00000041640.3
|
Ankmy2
|
ankyrin repeat and MYND domain containing 2 |
chr6_-_124768330 | 2.36 |
ENSMUST00000135626.1
|
Eno2
|
enolase 2, gamma neuronal |
chr1_-_37865040 | 2.35 |
ENSMUST00000041815.8
|
Tsga10
|
testis specific 10 |
chr17_+_35823509 | 2.35 |
ENSMUST00000173493.1
ENSMUST00000173147.1 ENSMUST00000172846.1 |
Flot1
|
flotillin 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 11.6 | GO:0097494 | regulation of vesicle size(GO:0097494) |
2.1 | 6.4 | GO:1902605 | heterotrimeric G-protein complex assembly(GO:1902605) |
2.1 | 10.6 | GO:0051012 | microtubule sliding(GO:0051012) |
1.9 | 7.8 | GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
1.8 | 5.5 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
1.8 | 10.6 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
1.8 | 1.8 | GO:1900673 | olefin metabolic process(GO:1900673) |
1.7 | 7.0 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
1.7 | 5.0 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
1.6 | 1.6 | GO:0035493 | SNARE complex assembly(GO:0035493) |
1.6 | 4.7 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
1.6 | 10.9 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.5 | 9.3 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
1.5 | 6.0 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
1.4 | 5.7 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
1.4 | 4.2 | GO:1902724 | positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
1.3 | 5.4 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
1.3 | 4.0 | GO:0072034 | renal vesicle induction(GO:0072034) |
1.3 | 5.3 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
1.3 | 3.9 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
1.3 | 8.9 | GO:0051775 | response to redox state(GO:0051775) |
1.2 | 5.0 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
1.2 | 5.0 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
1.2 | 2.5 | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
1.2 | 9.7 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
1.2 | 3.6 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
1.2 | 3.6 | GO:0014055 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
1.2 | 10.6 | GO:0090166 | Golgi disassembly(GO:0090166) |
1.2 | 4.7 | GO:0030070 | insulin processing(GO:0030070) |
1.2 | 4.6 | GO:0034031 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
1.1 | 4.6 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
1.1 | 5.7 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
1.1 | 3.4 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
1.1 | 6.8 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
1.1 | 3.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
1.0 | 3.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.0 | 6.1 | GO:0070417 | cellular response to cold(GO:0070417) |
1.0 | 3.1 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
1.0 | 4.1 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
1.0 | 1.0 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
1.0 | 5.1 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
1.0 | 3.0 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
1.0 | 4.9 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
1.0 | 11.6 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.9 | 2.8 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.9 | 4.6 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.9 | 2.8 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
0.9 | 1.8 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.9 | 4.5 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.9 | 8.0 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.9 | 3.6 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
0.9 | 3.5 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
0.9 | 3.5 | GO:0021586 | pons maturation(GO:0021586) |
0.9 | 1.7 | GO:1990868 | response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
0.9 | 6.9 | GO:0034651 | cortisol metabolic process(GO:0034650) cortisol biosynthetic process(GO:0034651) |
0.9 | 2.6 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.9 | 0.9 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
0.9 | 2.6 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.9 | 4.3 | GO:1990839 | response to endothelin(GO:1990839) |
0.9 | 4.3 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.9 | 2.6 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.8 | 3.4 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.8 | 2.5 | GO:0060932 | atrioventricular bundle cell differentiation(GO:0003167) His-Purkinje system cell differentiation(GO:0060932) |
0.8 | 1.7 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.8 | 2.5 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.8 | 4.1 | GO:0021564 | vagus nerve development(GO:0021564) |
0.8 | 4.0 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.8 | 5.6 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.8 | 5.5 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.8 | 1.6 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.8 | 2.3 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.8 | 3.1 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.8 | 1.5 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.8 | 0.8 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.8 | 2.3 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
0.8 | 0.8 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
0.8 | 2.3 | GO:0060596 | mammary placode formation(GO:0060596) |
0.8 | 4.5 | GO:0036257 | multivesicular body organization(GO:0036257) multivesicular body assembly(GO:0036258) |
0.7 | 2.2 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.7 | 2.2 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.7 | 3.0 | GO:0090182 | regulation of secretion of lysosomal enzymes(GO:0090182) |
0.7 | 3.0 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.7 | 2.9 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.7 | 5.7 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.7 | 0.7 | GO:0010159 | specification of organ position(GO:0010159) |
0.7 | 2.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.7 | 0.7 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.7 | 2.1 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.7 | 2.8 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.7 | 0.7 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
0.7 | 3.5 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
0.7 | 1.4 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.7 | 1.4 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.7 | 2.1 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.7 | 0.7 | GO:0051832 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.7 | 2.0 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.7 | 6.1 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.7 | 4.0 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.7 | 1.3 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
0.7 | 3.4 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.7 | 0.7 | GO:1990118 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.7 | 2.0 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
0.7 | 0.7 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
0.7 | 4.6 | GO:0070054 | mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
0.7 | 3.3 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.7 | 2.0 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.7 | 7.9 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.7 | 1.3 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.7 | 3.3 | GO:1902023 | L-arginine transport(GO:1902023) |
0.6 | 3.2 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.6 | 2.6 | GO:1904453 | regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
0.6 | 3.2 | GO:1904717 | regulation of AMPA glutamate receptor clustering(GO:1904717) |
0.6 | 3.1 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.6 | 16.4 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.6 | 2.5 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.6 | 1.2 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.6 | 3.1 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.6 | 3.7 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.6 | 11.1 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.6 | 1.8 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.6 | 1.8 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
0.6 | 1.8 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.6 | 1.8 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
0.6 | 4.9 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.6 | 3.6 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.6 | 3.6 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.6 | 0.6 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.6 | 3.0 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.6 | 1.8 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.6 | 1.8 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.6 | 1.2 | GO:0003274 | endocardial cushion fusion(GO:0003274) |
0.6 | 1.8 | GO:0042197 | dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
0.6 | 0.6 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.6 | 5.9 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.6 | 2.9 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
0.6 | 4.7 | GO:0051611 | regulation of serotonin uptake(GO:0051611) |
0.6 | 4.6 | GO:0060214 | endocardium formation(GO:0060214) |
0.6 | 1.7 | GO:0061090 | positive regulation of sequestering of zinc ion(GO:0061090) |
0.6 | 2.3 | GO:0043308 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.6 | 2.8 | GO:0002159 | desmosome assembly(GO:0002159) |
0.6 | 0.6 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.6 | 1.7 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) positive regulation of cellular pH reduction(GO:0032849) |
0.6 | 1.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.6 | 2.2 | GO:0072566 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.6 | 5.0 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.6 | 1.7 | GO:0046021 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.6 | 3.9 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.6 | 7.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.5 | 1.6 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.5 | 3.8 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.5 | 2.7 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.5 | 1.6 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.5 | 3.8 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.5 | 1.1 | GO:0045168 | cell-cell signaling involved in cell fate commitment(GO:0045168) |
0.5 | 1.6 | GO:0015866 | ADP transport(GO:0015866) |
0.5 | 3.8 | GO:0015675 | nickel cation transport(GO:0015675) |
0.5 | 2.7 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.5 | 2.7 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.5 | 2.1 | GO:0046898 | response to cycloheximide(GO:0046898) |
0.5 | 1.6 | GO:0001928 | regulation of exocyst assembly(GO:0001928) |
0.5 | 4.7 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.5 | 1.1 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.5 | 3.2 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.5 | 0.5 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.5 | 1.6 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.5 | 3.1 | GO:0090383 | phagosome acidification(GO:0090383) |
0.5 | 1.6 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
0.5 | 2.1 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.5 | 2.6 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.5 | 1.6 | GO:2000382 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) positive regulation of mesoderm development(GO:2000382) |
0.5 | 1.0 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.5 | 4.7 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.5 | 1.6 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.5 | 0.5 | GO:0098712 | amino acid import across plasma membrane(GO:0089718) L-glutamate import across plasma membrane(GO:0098712) |
0.5 | 1.0 | GO:0060066 | oviduct development(GO:0060066) |
0.5 | 0.5 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.5 | 0.5 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.5 | 1.5 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.5 | 1.0 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.5 | 5.1 | GO:0046959 | habituation(GO:0046959) |
0.5 | 2.0 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.5 | 1.5 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.5 | 0.5 | GO:0045176 | apical protein localization(GO:0045176) |
0.5 | 2.0 | GO:0009597 | detection of virus(GO:0009597) |
0.5 | 1.0 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.5 | 2.0 | GO:0030026 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
0.5 | 1.0 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.5 | 2.0 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.5 | 4.0 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.5 | 2.5 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.5 | 4.4 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.5 | 1.0 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.5 | 1.5 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.5 | 1.5 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.5 | 3.9 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.5 | 4.4 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.5 | 3.9 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.5 | 1.5 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
0.5 | 1.0 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.5 | 0.5 | GO:0009153 | purine deoxyribonucleotide biosynthetic process(GO:0009153) |
0.5 | 1.4 | GO:1905034 | regulation of antifungal innate immune response(GO:1905034) negative regulation of antifungal innate immune response(GO:1905035) |
0.5 | 1.4 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
0.5 | 1.4 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.5 | 0.5 | GO:0071211 | protein targeting to vacuole involved in autophagy(GO:0071211) |
0.5 | 2.9 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.5 | 0.5 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.5 | 1.4 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.5 | 2.8 | GO:0032439 | endosome localization(GO:0032439) |
0.5 | 5.2 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.5 | 3.3 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.5 | 2.3 | GO:0033762 | response to glucagon(GO:0033762) |
0.5 | 0.9 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.5 | 2.8 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.5 | 0.9 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.5 | 1.9 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.5 | 2.3 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.5 | 0.5 | GO:0031944 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.5 | 0.9 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
0.5 | 7.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.5 | 1.8 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.5 | 0.9 | GO:1901731 | positive regulation of platelet aggregation(GO:1901731) |
0.5 | 4.1 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.5 | 1.8 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.5 | 3.2 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.4 | 7.6 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.4 | 5.8 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.4 | 3.6 | GO:0006903 | vesicle targeting(GO:0006903) |
0.4 | 2.2 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.4 | 0.9 | GO:1904579 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.4 | 0.4 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.4 | 0.9 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.4 | 0.9 | GO:0048611 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
0.4 | 1.8 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) fatty-acyl-CoA catabolic process(GO:0036115) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.4 | 1.8 | GO:1904109 | positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) positive regulation of cholesterol import(GO:1904109) positive regulation of sterol import(GO:2000911) |
0.4 | 1.8 | GO:0072125 | negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
0.4 | 1.8 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.4 | 4.4 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.4 | 1.8 | GO:0048069 | eye pigmentation(GO:0048069) |
0.4 | 1.8 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.4 | 4.8 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.4 | 3.5 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.4 | 0.9 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.4 | 0.4 | GO:0072162 | metanephric mesenchymal cell differentiation(GO:0072162) |
0.4 | 0.9 | GO:0070384 | Harderian gland development(GO:0070384) |
0.4 | 0.4 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.4 | 3.9 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.4 | 4.3 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.4 | 1.7 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
0.4 | 1.7 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
0.4 | 0.4 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
0.4 | 2.1 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.4 | 2.1 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.4 | 0.4 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.4 | 1.3 | GO:1901629 | regulation of presynaptic membrane organization(GO:1901629) |
0.4 | 0.8 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.4 | 3.8 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
0.4 | 0.8 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.4 | 1.7 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.4 | 2.9 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.4 | 0.8 | GO:0051088 | monocyte activation(GO:0042117) PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.4 | 3.3 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.4 | 1.2 | GO:2000864 | estradiol secretion(GO:0035938) regulation of estradiol secretion(GO:2000864) |
0.4 | 2.5 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.4 | 3.7 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.4 | 0.8 | GO:0030862 | positive regulation of polarized epithelial cell differentiation(GO:0030862) |
0.4 | 4.5 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.4 | 2.4 | GO:0015889 | cobalamin transport(GO:0015889) |
0.4 | 0.8 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.4 | 1.6 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.4 | 1.2 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.4 | 3.6 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.4 | 2.4 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.4 | 1.2 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.4 | 2.0 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.4 | 1.2 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.4 | 2.3 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.4 | 0.8 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.4 | 0.4 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.4 | 1.2 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
0.4 | 3.5 | GO:0051026 | chiasma assembly(GO:0051026) |
0.4 | 1.2 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
0.4 | 1.2 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.4 | 5.0 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.4 | 3.5 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.4 | 1.5 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.4 | 1.5 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.4 | 1.9 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.4 | 0.8 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.4 | 3.8 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.4 | 1.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.4 | 2.6 | GO:0002934 | desmosome organization(GO:0002934) |
0.4 | 1.9 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.4 | 3.4 | GO:0071569 | protein ufmylation(GO:0071569) |
0.4 | 1.1 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.4 | 1.5 | GO:0015671 | oxygen transport(GO:0015671) |
0.4 | 4.5 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.4 | 0.4 | GO:0070459 | prolactin secretion(GO:0070459) |
0.4 | 2.2 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.4 | 5.5 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.4 | 8.9 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.4 | 1.8 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.4 | 1.5 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.4 | 2.2 | GO:0015871 | choline transport(GO:0015871) |
0.4 | 5.1 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.4 | 5.5 | GO:0015816 | glycine transport(GO:0015816) |
0.4 | 4.4 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.4 | 4.7 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.4 | 4.3 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.4 | 1.4 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.4 | 1.8 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.4 | 1.4 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.4 | 0.7 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.4 | 0.7 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.4 | 0.7 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
0.4 | 2.2 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.4 | 1.4 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.4 | 6.8 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.4 | 0.7 | GO:0060466 | activation of meiosis involved in egg activation(GO:0060466) |
0.4 | 1.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.4 | 2.1 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.4 | 0.7 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.4 | 1.8 | GO:0019086 | late viral transcription(GO:0019086) |
0.4 | 2.5 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.4 | 1.4 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) |
0.3 | 1.0 | GO:1903297 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.3 | 2.8 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.3 | 0.7 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.3 | 0.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.3 | 0.3 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.3 | 0.3 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.3 | 0.3 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.3 | 2.1 | GO:2000564 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
0.3 | 1.0 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
0.3 | 2.1 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.3 | 2.1 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.3 | 1.0 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
0.3 | 9.2 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.3 | 1.4 | GO:0061187 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.3 | 1.4 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.3 | 0.7 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.3 | 1.4 | GO:0060003 | copper ion export(GO:0060003) |
0.3 | 3.0 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.3 | 1.7 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.3 | 0.3 | GO:0001878 | response to yeast(GO:0001878) |
0.3 | 1.0 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.3 | 0.7 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.3 | 1.0 | GO:0071846 | actin filament debranching(GO:0071846) |
0.3 | 0.7 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.3 | 1.0 | GO:1905167 | astrocyte activation involved in immune response(GO:0002265) positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.3 | 1.3 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.3 | 2.3 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.3 | 0.7 | GO:0097106 | postsynaptic density organization(GO:0097106) |
0.3 | 0.7 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.3 | 0.3 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.3 | 1.6 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.3 | 1.0 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
0.3 | 3.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 3.2 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.3 | 1.0 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.3 | 2.9 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
0.3 | 1.3 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.3 | 1.0 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.3 | 0.3 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.3 | 3.5 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.3 | 1.9 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.3 | 0.6 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
0.3 | 0.9 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.3 | 0.6 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.3 | 4.0 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.3 | 0.9 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.3 | 1.5 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.3 | 4.3 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.3 | 2.2 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.3 | 0.6 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.3 | 0.9 | GO:0046449 | allantoin metabolic process(GO:0000255) creatinine metabolic process(GO:0046449) |
0.3 | 0.9 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.3 | 0.3 | GO:0070723 | response to cholesterol(GO:0070723) |
0.3 | 4.9 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.3 | 1.2 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.3 | 1.5 | GO:0070432 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
0.3 | 0.9 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.3 | 1.5 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.3 | 3.0 | GO:0032464 | regulation of protein homooligomerization(GO:0032462) positive regulation of protein homooligomerization(GO:0032464) |
0.3 | 5.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.3 | 1.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.3 | 0.3 | GO:0080144 | amino acid homeostasis(GO:0080144) |
0.3 | 1.5 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
0.3 | 0.6 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.3 | 2.4 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.3 | 0.3 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.3 | 1.8 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
0.3 | 0.9 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
0.3 | 0.3 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.3 | 0.9 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.3 | 3.0 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.3 | 0.6 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.3 | 1.2 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.3 | 0.6 | GO:0009405 | pathogenesis(GO:0009405) |
0.3 | 2.4 | GO:0070423 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.3 | 0.6 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.3 | 2.3 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.3 | 0.3 | GO:0035802 | adrenal cortex development(GO:0035801) adrenal cortex formation(GO:0035802) |
0.3 | 1.5 | GO:1905171 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
0.3 | 0.3 | GO:0015827 | aromatic amino acid transport(GO:0015801) tryptophan transport(GO:0015827) |
0.3 | 0.3 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.3 | 2.3 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.3 | 1.5 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.3 | 0.6 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
0.3 | 0.3 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.3 | 1.5 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.3 | 3.5 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.3 | 0.3 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.3 | 3.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.3 | 2.6 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.3 | 2.6 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.3 | 0.6 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
0.3 | 1.4 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.3 | 0.6 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.3 | 0.6 | GO:0009212 | dTTP biosynthetic process(GO:0006235) deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.3 | 1.4 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.3 | 1.4 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.3 | 4.0 | GO:0019236 | response to pheromone(GO:0019236) |
0.3 | 1.1 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.3 | 3.1 | GO:0097264 | self proteolysis(GO:0097264) |
0.3 | 1.7 | GO:1901911 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.3 | 2.8 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.3 | 0.3 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.3 | 0.8 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.3 | 1.7 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.3 | 1.4 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.3 | 1.4 | GO:0021886 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
0.3 | 1.7 | GO:0032367 | intracellular lipid transport(GO:0032365) intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.3 | 1.1 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.3 | 0.8 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.3 | 5.2 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.3 | 1.6 | GO:0003383 | apical constriction(GO:0003383) |
0.3 | 2.2 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.3 | 1.1 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.3 | 0.5 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.3 | 1.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.3 | 0.5 | GO:0006710 | androgen catabolic process(GO:0006710) |
0.3 | 1.1 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.3 | 1.1 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
0.3 | 0.8 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.3 | 1.6 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.3 | 3.8 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.3 | 0.5 | GO:0015961 | diadenosine polyphosphate catabolic process(GO:0015961) |
0.3 | 0.5 | GO:0046882 | negative regulation of gonadotropin secretion(GO:0032277) negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.3 | 1.3 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
0.3 | 7.7 | GO:0032456 | endocytic recycling(GO:0032456) |
0.3 | 0.5 | GO:0090114 | COPII-coated vesicle budding(GO:0090114) |
0.3 | 1.1 | GO:0071864 | positive regulation of cell proliferation in bone marrow(GO:0071864) |
0.3 | 1.1 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.3 | 0.5 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.3 | 5.0 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.3 | 0.5 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.3 | 3.2 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.3 | 1.1 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.3 | 0.3 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.3 | 0.5 | GO:0072007 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
0.3 | 1.1 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.3 | 1.8 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.3 | 0.3 | GO:0001575 | globoside metabolic process(GO:0001575) |
0.3 | 0.8 | GO:1901249 | regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
0.3 | 0.3 | GO:0072244 | metanephric glomerular epithelium development(GO:0072244) |
0.3 | 2.1 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.3 | 0.5 | GO:0002268 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.3 | 0.5 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.3 | 4.1 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.3 | 1.5 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.3 | 0.5 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.3 | 0.8 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.3 | 0.5 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
0.3 | 1.0 | GO:0031938 | regulation of chromatin silencing at telomere(GO:0031938) |
0.3 | 0.8 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.3 | 1.8 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.3 | 9.9 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.3 | 1.5 | GO:0098963 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
0.3 | 0.5 | GO:1903243 | negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
0.3 | 2.3 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.3 | 1.5 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.3 | 0.3 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
0.3 | 2.0 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.3 | 2.8 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.3 | 4.0 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.3 | 1.3 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.2 | 1.0 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.2 | 0.5 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.2 | 0.5 | GO:2000742 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.2 | 1.0 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.2 | 1.5 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.2 | 0.2 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.2 | 0.5 | GO:0031179 | peptide modification(GO:0031179) |
0.2 | 3.2 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.2 | 0.7 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.2 | 2.2 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.2 | 0.5 | GO:0021843 | substrate-independent telencephalic tangential migration(GO:0021826) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
0.2 | 1.5 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.2 | 4.1 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.2 | 0.5 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) |
0.2 | 0.7 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.2 | 0.5 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.2 | 1.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.2 | 1.4 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.2 | 0.7 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.2 | 1.4 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.2 | 1.9 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.2 | 0.7 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
0.2 | 0.7 | GO:0060489 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
0.2 | 0.5 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) glucose 1-phosphate metabolic process(GO:0019255) |
0.2 | 1.9 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.2 | 0.9 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.2 | 1.6 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 0.2 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.2 | 0.9 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.2 | 0.7 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.2 | 0.9 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.2 | 0.5 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.2 | 5.1 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.2 | 0.5 | GO:1904100 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.2 | 4.6 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.2 | 2.8 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.2 | 0.9 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.2 | 0.9 | GO:0060180 | female mating behavior(GO:0060180) |
0.2 | 0.9 | GO:0015817 | histidine transport(GO:0015817) |
0.2 | 1.8 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.2 | 2.0 | GO:0030238 | male sex determination(GO:0030238) |
0.2 | 0.5 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.2 | 0.9 | GO:0015886 | heme transport(GO:0015886) |
0.2 | 1.6 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.2 | 0.2 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.2 | 0.7 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.2 | 0.5 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.2 | 1.6 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.2 | 2.0 | GO:0097186 | amelogenesis(GO:0097186) |
0.2 | 0.7 | GO:0046755 | viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
0.2 | 0.7 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 0.7 | GO:0051593 | response to folic acid(GO:0051593) |
0.2 | 0.2 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
0.2 | 1.1 | GO:1902564 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) negative regulation of neutrophil activation(GO:1902564) |
0.2 | 0.4 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.2 | 0.7 | GO:0000429 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
0.2 | 0.2 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
0.2 | 0.9 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.2 | 0.2 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 2.4 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.2 | 0.4 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.2 | 2.4 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.2 | 0.9 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.2 | 0.9 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.2 | 0.2 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.2 | 0.4 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.2 | 0.4 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.2 | 0.7 | GO:1900149 | positive regulation of Schwann cell migration(GO:1900149) |
0.2 | 1.8 | GO:0042148 | strand invasion(GO:0042148) |
0.2 | 12.5 | GO:0007566 | embryo implantation(GO:0007566) |
0.2 | 0.7 | GO:0048340 | paraxial mesoderm morphogenesis(GO:0048340) |
0.2 | 0.9 | GO:0098969 | neurotransmitter receptor transport to postsynaptic membrane(GO:0098969) establishment of protein localization to postsynaptic membrane(GO:1903540) |
0.2 | 1.5 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.2 | 0.4 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.2 | 1.5 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.2 | 0.4 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
0.2 | 0.4 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
0.2 | 0.9 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
0.2 | 0.2 | GO:0043519 | myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
0.2 | 0.9 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.2 | 1.9 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.2 | 0.2 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.2 | 0.2 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.2 | 0.4 | GO:0090009 | primitive streak formation(GO:0090009) |
0.2 | 1.9 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.2 | 2.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 0.4 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.2 | 3.0 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
0.2 | 1.1 | GO:0072033 | renal vesicle formation(GO:0072033) |
0.2 | 0.4 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.2 | 0.6 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.2 | 0.6 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
0.2 | 0.8 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 1.0 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.2 | 0.8 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) |
0.2 | 0.2 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.2 | 0.6 | GO:0032917 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.2 | 1.0 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.2 | 0.6 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 0.2 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.2 | 0.6 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.2 | 0.4 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.2 | 0.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.2 | 0.2 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.2 | 1.8 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.2 | 5.7 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 1.8 | GO:0043084 | penile erection(GO:0043084) |
0.2 | 0.8 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.2 | 0.8 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.2 | 1.4 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.2 | 0.6 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) cellular response to sodium arsenite(GO:1903936) |
0.2 | 0.2 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.2 | 2.4 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.2 | 0.8 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.2 | 2.8 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.2 | 0.6 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.2 | 4.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 0.6 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
0.2 | 2.6 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.2 | 0.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.2 | 0.6 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.2 | 0.6 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.2 | 10.2 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.2 | 0.6 | GO:0060785 | regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
0.2 | 1.2 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.2 | 0.8 | GO:0009115 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.2 | 2.1 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.2 | 0.6 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.2 | 0.4 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.2 | 1.3 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.2 | 0.6 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.2 | 0.2 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.2 | 3.8 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.2 | 0.6 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.2 | 5.1 | GO:0048240 | sperm capacitation(GO:0048240) |
0.2 | 1.1 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 2.3 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.2 | 2.1 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.2 | 0.9 | GO:0060290 | transdifferentiation(GO:0060290) |
0.2 | 0.6 | GO:0014889 | muscle atrophy(GO:0014889) |
0.2 | 0.2 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.2 | 1.8 | GO:0032098 | regulation of appetite(GO:0032098) |
0.2 | 1.5 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.2 | 0.7 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 1.1 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.2 | 0.6 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
0.2 | 5.3 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.2 | 0.9 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.2 | 1.5 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.2 | 2.2 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.2 | 0.4 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) positive regulation of adenosine receptor signaling pathway(GO:0060168) |
0.2 | 1.3 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.2 | 0.7 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.2 | 0.5 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.2 | 0.7 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.2 | 1.2 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 1.6 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.2 | 0.5 | GO:0006983 | ER overload response(GO:0006983) |
0.2 | 0.2 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.2 | 0.5 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.2 | 0.2 | GO:0061402 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
0.2 | 9.0 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.2 | 0.2 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) |
0.2 | 0.5 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
0.2 | 0.2 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.2 | 3.3 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.2 | 0.5 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.2 | 0.7 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.2 | 0.3 | GO:2000849 | glucocorticoid secretion(GO:0035933) regulation of glucocorticoid secretion(GO:2000849) |
0.2 | 0.7 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.2 | 1.0 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 2.7 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.2 | 1.4 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.2 | 1.5 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.2 | 0.8 | GO:0002838 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.2 | 0.3 | GO:1903275 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.2 | 0.5 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) nucleoside transmembrane transport(GO:1901642) |
0.2 | 0.3 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.2 | 3.7 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.2 | 0.5 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.2 | 0.3 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.2 | 1.7 | GO:0010225 | response to UV-C(GO:0010225) |
0.2 | 0.8 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.2 | 0.2 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.2 | 0.7 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.2 | 0.2 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
0.2 | 0.7 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.2 | 1.8 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.2 | 0.7 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.2 | 0.5 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.2 | 1.0 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 0.5 | GO:0007320 | insemination(GO:0007320) |
0.2 | 0.8 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.2 | 0.6 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.2 | 0.3 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.2 | 0.5 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.2 | 1.5 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.2 | 1.4 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.2 | 0.3 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.2 | 0.3 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.2 | 2.1 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.2 | 1.3 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.2 | 1.4 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.2 | 2.5 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 0.6 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.2 | 2.5 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.2 | 1.1 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.2 | 0.8 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.2 | 0.9 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.2 | 1.1 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.2 | 0.5 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.2 | 1.1 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.2 | 0.9 | GO:0051665 | membrane raft localization(GO:0051665) |
0.2 | 0.5 | GO:0001193 | maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
0.2 | 0.9 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.2 | 0.5 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.1 | 0.9 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.3 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.1 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.1 | 0.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 0.7 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.1 | 0.7 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
0.1 | 2.4 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.1 | 0.3 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.1 | 0.6 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.3 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.1 | 0.6 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.1 | 0.4 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.1 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.1 | 0.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.1 | 0.3 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.1 | 0.9 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.1 | 0.4 | GO:0071694 | sequestering of extracellular ligand from receptor(GO:0035581) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.4 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.1 | 0.7 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.1 | GO:0048664 | neuron fate determination(GO:0048664) |
0.1 | 0.1 | GO:0019732 | antifungal humoral response(GO:0019732) antifungal innate immune response(GO:0061760) |
0.1 | 1.3 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.1 | 3.4 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.1 | 0.4 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 0.1 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.1 | 0.4 | GO:0010816 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.1 | 0.1 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.1 | 0.6 | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
0.1 | 0.4 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.1 | 0.7 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.1 | 1.3 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.1 | 0.3 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) |
0.1 | 6.5 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.1 | 0.5 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.1 | 0.4 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.1 | 0.5 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.1 | 1.1 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.1 | 0.1 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.1 | 0.3 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.1 | 1.8 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 1.7 | GO:0042755 | eating behavior(GO:0042755) |
0.1 | 0.3 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.1 | 0.5 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.1 | 1.9 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.1 | 0.7 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.1 | 0.3 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 0.4 | GO:0032274 | gonadotropin secretion(GO:0032274) |
0.1 | 2.0 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
0.1 | 0.4 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.1 | 3.3 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 1.2 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.5 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.4 | GO:0072182 | regulation of nephron tubule epithelial cell differentiation(GO:0072182) |
0.1 | 1.2 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.1 | 0.5 | GO:0009414 | response to water deprivation(GO:0009414) |
0.1 | 0.1 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.1 | 2.0 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.1 | 0.4 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.4 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 0.6 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.1 | 0.8 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 0.6 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.1 | 0.1 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.1 | 0.3 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.1 | 0.3 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.1 | 0.9 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.1 | 0.5 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.1 | 0.5 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.1 | 2.6 | GO:1903078 | positive regulation of protein localization to plasma membrane(GO:1903078) |
0.1 | 0.6 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 0.2 | GO:0007530 | sex determination(GO:0007530) |
0.1 | 0.2 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.1 | 0.2 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.1 | 3.5 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 0.5 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.1 | 0.1 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 0.2 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.1 | 5.9 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.7 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.1 | GO:0046958 | nonassociative learning(GO:0046958) |
0.1 | 1.8 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 1.0 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.1 | 0.5 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.1 | 0.4 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.1 | 0.1 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.1 | 0.2 | GO:0052564 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
0.1 | 0.5 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.1 | 0.2 | GO:0072683 | T cell extravasation(GO:0072683) regulation of T cell extravasation(GO:2000407) positive regulation of T cell extravasation(GO:2000409) |
0.1 | 0.4 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.1 | 0.1 | GO:0071440 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K14 acetylation(GO:0071440) regulation of histone H3-K27 acetylation(GO:1901674) |
0.1 | 1.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.9 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 0.1 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.1 | 0.8 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.1 | 0.5 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.3 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 1.3 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.1 | 0.6 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) |
0.1 | 0.3 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.1 | 0.1 | GO:2000303 | regulation of ceramide biosynthetic process(GO:2000303) |
0.1 | 0.7 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.1 | 0.2 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.1 | 0.2 | GO:0060838 | lymphatic endothelial cell fate commitment(GO:0060838) |
0.1 | 0.2 | GO:0044849 | estrous cycle(GO:0044849) |
0.1 | 0.4 | GO:0010286 | heat acclimation(GO:0010286) |
0.1 | 1.1 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) regulation of establishment of protein localization to plasma membrane(GO:0090003) |
0.1 | 1.4 | GO:0002931 | response to ischemia(GO:0002931) |
0.1 | 0.4 | GO:0097298 | regulation of nucleus size(GO:0097298) |
0.1 | 0.8 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.8 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.4 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.1 | 0.5 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 0.5 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.7 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.1 | GO:0061511 | centriole elongation(GO:0061511) |
0.1 | 0.5 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 2.2 | GO:0045661 | regulation of myoblast differentiation(GO:0045661) |
0.1 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.2 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.1 | 0.5 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 1.5 | GO:0007520 | myoblast fusion(GO:0007520) |
0.1 | 0.4 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.1 | 0.4 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.1 | GO:0072368 | regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
0.1 | 0.3 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.8 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.1 | 0.8 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.1 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.1 | 0.2 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
0.1 | 0.8 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.1 | 0.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.3 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.1 | 0.9 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.1 | 0.4 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 1.2 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.1 | 0.4 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.1 | 2.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.3 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 2.0 | GO:0044243 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
0.1 | 1.1 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 1.0 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.1 | 0.1 | GO:0021612 | facial nerve structural organization(GO:0021612) |
0.1 | 0.6 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 0.5 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.1 | 0.2 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 0.4 | GO:0006788 | heme oxidation(GO:0006788) |
0.1 | 0.9 | GO:0090335 | regulation of brown fat cell differentiation(GO:0090335) |
0.1 | 0.3 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.1 | 0.1 | GO:1900738 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.1 | 1.6 | GO:0003170 | heart valve development(GO:0003170) |
0.1 | 1.5 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 2.1 | GO:0001881 | receptor recycling(GO:0001881) |
0.1 | 0.4 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.1 | 0.8 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
0.1 | 0.3 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.1 | 1.7 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.1 | 0.5 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.1 | 0.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 1.3 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.2 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 3.4 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
0.1 | 0.5 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.1 | 1.1 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 0.7 | GO:0090311 | regulation of protein deacetylation(GO:0090311) |
0.1 | 0.5 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 1.4 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.1 | 1.8 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 0.7 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.9 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.3 | GO:2000110 | protein sialylation(GO:1990743) negative regulation of macrophage apoptotic process(GO:2000110) |
0.1 | 0.3 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 0.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 0.7 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.2 | GO:0010226 | response to lithium ion(GO:0010226) |
0.1 | 0.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.3 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 3.9 | GO:0051057 | positive regulation of small GTPase mediated signal transduction(GO:0051057) |
0.1 | 0.4 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.1 | 0.3 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.1 | 1.6 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.4 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.1 | 0.6 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.3 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.1 | 0.2 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.3 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.1 | 1.0 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 1.4 | GO:0005980 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.1 | 0.1 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.1 | 4.2 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.1 | 0.2 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.1 | 1.0 | GO:0006497 | protein lipidation(GO:0006497) |
0.1 | 0.3 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.1 | 0.9 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.2 | GO:0048840 | otolith morphogenesis(GO:0032474) otolith development(GO:0048840) |
0.1 | 1.6 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.1 | 1.4 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.1 | 0.1 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.1 | 0.7 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 0.8 | GO:0010043 | response to zinc ion(GO:0010043) |
0.1 | 0.2 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 0.1 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.1 | 0.4 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.1 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.2 | GO:0009397 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
0.1 | 0.8 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.8 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.8 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 1.2 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.1 | 1.0 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.1 | 0.3 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
0.1 | 0.2 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.6 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.1 | 0.2 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.1 | 3.4 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
0.1 | 0.3 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.1 | 0.3 | GO:0007618 | mating(GO:0007618) |
0.1 | 0.2 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.1 | 0.5 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 1.0 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.1 | 0.4 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) regulation of kinetochore assembly(GO:0090234) |
0.1 | 0.3 | GO:0032532 | regulation of microvillus organization(GO:0032530) regulation of microvillus length(GO:0032532) |
0.1 | 0.1 | GO:0042976 | activation of Janus kinase activity(GO:0042976) |
0.1 | 3.3 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.1 | 1.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.5 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.1 | 0.5 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.1 | 3.1 | GO:0005977 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.1 | 0.3 | GO:0051798 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.1 | 0.2 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 0.1 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.1 | 0.3 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.5 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.1 | 0.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.4 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
0.1 | 0.2 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.1 | 0.1 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.1 | 0.1 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) negative regulation of mitophagy(GO:1903147) |
0.1 | 0.4 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.1 | 0.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.4 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 0.6 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.4 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.3 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.1 | 0.2 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.1 | 0.2 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.1 | 0.1 | GO:0045113 | integrin biosynthetic process(GO:0045112) regulation of integrin biosynthetic process(GO:0045113) |
0.1 | 0.3 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 0.3 | GO:0032225 | regulation of synaptic transmission, dopaminergic(GO:0032225) |
0.1 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.3 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.1 | 0.3 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.3 | GO:0010575 | positive regulation of vascular endothelial growth factor production(GO:0010575) |
0.1 | 1.2 | GO:1902186 | regulation of viral release from host cell(GO:1902186) |
0.1 | 0.1 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
0.1 | 0.3 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.1 | 0.4 | GO:0060770 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 1.6 | GO:0032835 | glomerulus development(GO:0032835) |
0.1 | 0.1 | GO:1902306 | negative regulation of sodium ion transmembrane transport(GO:1902306) |
0.1 | 0.2 | GO:1901623 | regulation of lymphocyte chemotaxis(GO:1901623) |
0.1 | 0.1 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.1 | 0.2 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.1 | 0.4 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.3 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) telencephalon regionalization(GO:0021978) |
0.1 | 1.2 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.1 | 0.7 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 2.6 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.4 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.1 | 0.1 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 2.3 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 0.2 | GO:0010224 | response to UV-B(GO:0010224) |
0.1 | 0.6 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 2.5 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 1.2 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 0.1 | GO:0035989 | tendon development(GO:0035989) |
0.1 | 0.4 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 0.1 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 0.2 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
0.1 | 0.2 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 0.9 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.5 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 1.8 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 1.3 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.1 | 0.1 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.1 | 0.3 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.1 | 0.8 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.1 | 0.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.2 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.5 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.3 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 0.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 0.7 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 1.9 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.1 | 0.2 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.1 | 0.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.2 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.6 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.4 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.1 | 0.8 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
0.1 | 1.0 | GO:0019228 | neuronal action potential(GO:0019228) |
0.1 | 0.3 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.0 | 0.0 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.0 | 1.5 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.3 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.0 | 0.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.0 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
0.0 | 1.5 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.2 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.0 | 0.1 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.0 | 0.4 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.0 | 0.0 | GO:0001927 | exocyst assembly(GO:0001927) |
0.0 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.0 | 0.2 | GO:0070633 | transepithelial transport(GO:0070633) |
0.0 | 0.2 | GO:0042119 | neutrophil activation(GO:0042119) |
0.0 | 0.1 | GO:2001271 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.0 | 0.2 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.0 | 0.3 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.0 | 0.3 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.0 | 0.2 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.0 | 0.2 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
0.0 | 1.0 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
0.0 | 0.1 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.0 | 0.1 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.0 | 0.4 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
0.0 | 0.3 | GO:0042182 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) ketone catabolic process(GO:0042182) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.0 | 0.0 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.0 | 0.1 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.0 | 0.1 | GO:0034104 | negative regulation of tissue remodeling(GO:0034104) |
0.0 | 0.1 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 0.1 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.2 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.0 | 0.3 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.0 | 0.0 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.0 | 0.5 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.0 | 0.3 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.1 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.0 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.7 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
0.0 | 0.3 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.8 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.1 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.0 | 0.1 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.0 | 0.1 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.0 | 0.1 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.0 | 0.1 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.0 | 0.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.1 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.0 | 0.1 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.0 | 0.1 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 0.1 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.0 | 0.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 0.8 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.5 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.0 | 0.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.3 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
0.0 | 0.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.0 | 0.1 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.0 | 0.1 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.0 | 0.1 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.0 | 0.1 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.0 | 0.0 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.1 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) basement membrane disassembly(GO:0034769) positive regulation of thyroid hormone generation(GO:2000611) |
0.0 | 0.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 0.2 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.0 | 0.8 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.0 | 0.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.0 | 0.1 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.0 | 0.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.0 | 0.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.0 | 0.1 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.0 | 0.3 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.0 | 0.2 | GO:0001964 | startle response(GO:0001964) |
0.0 | 0.5 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.0 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.1 | GO:0042158 | lipoprotein biosynthetic process(GO:0042158) |
0.0 | 0.1 | GO:0036035 | osteoclast development(GO:0036035) |
0.0 | 0.1 | GO:1901380 | negative regulation of potassium ion transmembrane transport(GO:1901380) |
0.0 | 0.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.2 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.0 | 0.2 | GO:0042311 | vasodilation(GO:0042311) |
0.0 | 0.3 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.0 | 0.2 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.0 | 0.4 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.4 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.2 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.0 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.0 | 0.2 | GO:0098586 | cellular response to virus(GO:0098586) |
0.0 | 1.4 | GO:0007601 | visual perception(GO:0007601) |
0.0 | 0.2 | GO:0009268 | response to pH(GO:0009268) |
0.0 | 0.3 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.2 | GO:0098876 | vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.0 | 0.1 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.0 | 0.0 | GO:0021941 | cerebellar cortex maturation(GO:0021699) radial glia guided migration of cerebellar granule cell(GO:0021933) negative regulation of cerebellar granule cell precursor proliferation(GO:0021941) |
0.0 | 0.0 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.1 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.0 | 0.2 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.0 | 0.0 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.0 | 0.1 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.0 | 0.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.2 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.0 | 0.1 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
0.0 | 0.0 | GO:0001887 | selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
0.0 | 0.1 | GO:0097028 | dendritic cell differentiation(GO:0097028) |
0.0 | 0.1 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.1 | GO:0001569 | patterning of blood vessels(GO:0001569) |
0.0 | 0.2 | GO:0043300 | regulation of leukocyte degranulation(GO:0043300) |
0.0 | 0.1 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.0 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.0 | 0.3 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.0 | 0.1 | GO:0006568 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.1 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.0 | 0.1 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.0 | 0.1 | GO:0080009 | mRNA methylation(GO:0080009) |
0.0 | 0.0 | GO:0048880 | sensory system development(GO:0048880) |
0.0 | 0.0 | GO:0032218 | riboflavin transport(GO:0032218) |
0.0 | 0.1 | GO:0051324 | meiotic prophase I(GO:0007128) prophase(GO:0051324) |
0.0 | 0.1 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.0 | 0.2 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.0 | 0.2 | GO:0061035 | regulation of cartilage development(GO:0061035) |
0.0 | 0.0 | GO:1904730 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 6.2 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
1.5 | 4.4 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
1.4 | 7.2 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
1.4 | 4.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.0 | 4.0 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
1.0 | 11.7 | GO:0043083 | synaptic cleft(GO:0043083) |
1.0 | 4.8 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.9 | 2.8 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
0.9 | 3.7 | GO:0005914 | spot adherens junction(GO:0005914) |
0.8 | 7.9 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.8 | 3.1 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.8 | 6.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.7 | 6.7 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
0.7 | 2.8 | GO:0071953 | elastic fiber(GO:0071953) |
0.6 | 2.6 | GO:1990794 | lateral part of cell(GO:0097574) basolateral part of cell(GO:1990794) rod bipolar cell terminal bouton(GO:1990795) |
0.6 | 2.6 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.6 | 1.9 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.6 | 5.0 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.6 | 3.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.6 | 4.8 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.6 | 7.7 | GO:0043219 | lateral loop(GO:0043219) |
0.6 | 14.7 | GO:0034706 | sodium channel complex(GO:0034706) |
0.6 | 4.1 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.6 | 1.7 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.6 | 1.1 | GO:0036019 | endolysosome(GO:0036019) |
0.6 | 5.6 | GO:0016600 | flotillin complex(GO:0016600) |
0.6 | 4.4 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.6 | 22.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.6 | 4.4 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.5 | 9.3 | GO:0000124 | SAGA complex(GO:0000124) |
0.5 | 3.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.5 | 2.2 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.5 | 1.1 | GO:0033263 | CORVET complex(GO:0033263) |
0.5 | 3.1 | GO:0043196 | varicosity(GO:0043196) |
0.5 | 3.6 | GO:0008091 | spectrin(GO:0008091) |
0.5 | 31.8 | GO:0034704 | calcium channel complex(GO:0034704) |
0.5 | 1.5 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.5 | 1.0 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
0.5 | 3.9 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.5 | 1.5 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.5 | 1.9 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.5 | 1.9 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
0.5 | 6.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.5 | 2.7 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.4 | 4.0 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.4 | 0.4 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.4 | 2.2 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.4 | 3.5 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.4 | 3.9 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.4 | 7.8 | GO:0035102 | PRC1 complex(GO:0035102) |
0.4 | 2.1 | GO:0070820 | tertiary granule(GO:0070820) |
0.4 | 1.3 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.4 | 1.2 | GO:0098855 | HCN channel complex(GO:0098855) |
0.4 | 1.6 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.4 | 3.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.4 | 1.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.4 | 2.0 | GO:0032433 | filopodium tip(GO:0032433) |
0.4 | 0.4 | GO:0031300 | intrinsic component of organelle membrane(GO:0031300) |
0.4 | 1.6 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.4 | 3.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.4 | 1.2 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.4 | 3.8 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.4 | 0.7 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.4 | 8.1 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.4 | 0.4 | GO:0097447 | dendritic tree(GO:0097447) |
0.4 | 0.7 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.4 | 20.9 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.4 | 5.0 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.4 | 1.1 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
0.4 | 2.1 | GO:0097443 | sorting endosome(GO:0097443) |
0.3 | 1.4 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.3 | 1.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 3.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.3 | 1.3 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.3 | 0.7 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.3 | 8.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 4.8 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 0.9 | GO:0048179 | activin receptor complex(GO:0048179) |
0.3 | 1.9 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.3 | 1.6 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.3 | 0.9 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.3 | 2.5 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.3 | 3.9 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.3 | 0.9 | GO:0044393 | microspike(GO:0044393) |
0.3 | 0.9 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 0.6 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.3 | 3.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.3 | 0.8 | GO:1990462 | omegasome(GO:1990462) |
0.3 | 2.0 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.3 | 2.5 | GO:0031983 | vesicle lumen(GO:0031983) |
0.3 | 0.6 | GO:0044753 | amphisome(GO:0044753) |
0.3 | 1.9 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.3 | 1.9 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.3 | 1.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.3 | 1.1 | GO:0033269 | internode region of axon(GO:0033269) |
0.3 | 4.0 | GO:0031105 | septin complex(GO:0031105) |
0.3 | 1.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.3 | 0.3 | GO:0002141 | stereocilia ankle link(GO:0002141) USH2 complex(GO:1990696) |
0.3 | 6.1 | GO:0043235 | receptor complex(GO:0043235) |
0.3 | 1.3 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.3 | 1.3 | GO:0070826 | paraferritin complex(GO:0070826) |
0.3 | 2.9 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 0.8 | GO:0031430 | M band(GO:0031430) |
0.3 | 5.2 | GO:0097225 | sperm midpiece(GO:0097225) |
0.3 | 2.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.3 | 3.1 | GO:0001533 | cornified envelope(GO:0001533) |
0.3 | 3.8 | GO:0033391 | chromatoid body(GO:0033391) |
0.3 | 1.5 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.3 | 0.8 | GO:0032280 | symmetric synapse(GO:0032280) |
0.3 | 6.0 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.2 | 0.5 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.2 | 0.7 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.2 | 0.5 | GO:0042611 | MHC protein complex(GO:0042611) |
0.2 | 0.7 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.2 | 0.7 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 2.2 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.2 | 0.5 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.2 | 1.2 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.2 | 1.0 | GO:0090537 | CERF complex(GO:0090537) |
0.2 | 3.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.2 | 4.7 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 3.0 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 4.1 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.2 | 0.5 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.2 | 1.1 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.2 | 0.9 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
0.2 | 0.7 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.2 | 0.7 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.2 | 1.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.2 | 1.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.2 | 1.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 2.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 0.6 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.2 | 1.1 | GO:1990745 | EARP complex(GO:1990745) |
0.2 | 2.1 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.2 | 26.7 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.2 | 3.5 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 1.7 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 2.7 | GO:0036157 | outer dynein arm(GO:0036157) |
0.2 | 6.6 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.2 | 0.8 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.2 | 0.8 | GO:0000802 | transverse filament(GO:0000802) |
0.2 | 0.2 | GO:0044432 | endoplasmic reticulum part(GO:0044432) |
0.2 | 2.2 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.2 | 0.2 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.2 | 1.2 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.2 | 0.6 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.2 | 1.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 2.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 1.7 | GO:0044754 | autolysosome(GO:0044754) |
0.2 | 3.9 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.2 | 1.3 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 0.4 | GO:0016011 | dystroglycan complex(GO:0016011) |
0.2 | 1.4 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.2 | 0.9 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.2 | 1.6 | GO:0016342 | catenin complex(GO:0016342) |
0.2 | 3.9 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.2 | 2.9 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.2 | 0.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.2 | 3.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 0.5 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.2 | 0.5 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 5.2 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 0.9 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
0.2 | 2.2 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.2 | 0.3 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.2 | 0.8 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.2 | 0.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 4.9 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 0.3 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 1.3 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.2 | 1.0 | GO:0030897 | HOPS complex(GO:0030897) |
0.2 | 0.8 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 3.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 0.5 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.2 | 2.5 | GO:0005605 | basal lamina(GO:0005605) |
0.2 | 2.3 | GO:0045179 | apical cortex(GO:0045179) |
0.2 | 1.3 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.2 | 0.7 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 2.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 1.0 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 3.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 1.4 | GO:0042599 | lamellar body(GO:0042599) |
0.2 | 0.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 2.7 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 2.1 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 0.8 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 1.4 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 0.3 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.2 | 0.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 0.8 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
0.1 | 0.6 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 2.9 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 0.4 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 1.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 6.8 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.1 | 3.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 2.0 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 2.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.6 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 7.2 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.8 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.8 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 0.8 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 0.4 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 1.7 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.3 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 1.9 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.1 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 5.6 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 1.6 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 16.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 1.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.6 | GO:0036396 | MIS complex(GO:0036396) |
0.1 | 9.9 | GO:0005930 | axoneme(GO:0005930) |
0.1 | 2.3 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.9 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 0.6 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.1 | 1.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.7 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.1 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.1 | 0.9 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 1.1 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 1.3 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.7 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.7 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.7 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.7 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.2 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.8 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 10.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.3 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.2 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.1 | 0.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 6.7 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 19.6 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 0.3 | GO:0034657 | GID complex(GO:0034657) |
0.1 | 0.2 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 1.3 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 0.4 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 2.7 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 10.5 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.1 | 1.9 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.1 | 3.9 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 1.7 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.3 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 1.9 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 5.9 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 0.3 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 2.9 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 55.4 | GO:0005768 | endosome(GO:0005768) |
0.1 | 2.8 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.1 | 1.5 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.3 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 1.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 1.0 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 0.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 23.3 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.7 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 2.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 7.8 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.6 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.9 | GO:0030133 | transport vesicle(GO:0030133) |
0.1 | 3.3 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 0.5 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.1 | 0.1 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.1 | 1.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 5.1 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.2 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.1 | 0.5 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 0.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.2 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 5.6 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 0.8 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 2.0 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 1.3 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.7 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 4.3 | GO:0012506 | vesicle membrane(GO:0012506) |
0.1 | 3.5 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.3 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.2 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 0.2 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 0.3 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.1 | 1.1 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 1.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.5 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.4 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 0.2 | GO:0099522 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
0.1 | 0.2 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 0.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.4 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 2.1 | GO:0005773 | vacuole(GO:0005773) |
0.1 | 0.2 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
0.1 | 46.9 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.1 | 0.4 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.4 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.0 | 0.2 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.0 | 0.3 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 1.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.2 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.0 | 0.2 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.3 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.0 | 4.5 | GO:0030141 | secretory granule(GO:0030141) |
0.0 | 1.3 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 7.0 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 0.0 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.0 | 0.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.4 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.0 | 0.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.0 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.0 | 40.8 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 0.9 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.1 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.0 | 0.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.1 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.0 | 0.3 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.4 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 94.4 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.3 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.1 | GO:0031417 | NatC complex(GO:0031417) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.6 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.0 | 0.0 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.0 | 0.0 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 18.7 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
2.3 | 9.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
2.2 | 6.6 | GO:0035939 | microsatellite binding(GO:0035939) |
1.9 | 7.6 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.8 | 12.9 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.6 | 1.6 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
1.6 | 7.9 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
1.6 | 6.2 | GO:0004104 | cholinesterase activity(GO:0004104) |
1.5 | 4.4 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
1.4 | 9.8 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.4 | 4.2 | GO:0005118 | sevenless binding(GO:0005118) |
1.3 | 4.0 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
1.3 | 5.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
1.3 | 3.8 | GO:0070615 | nucleosome-dependent ATPase activity(GO:0070615) |
1.2 | 7.4 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
1.2 | 4.7 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
1.1 | 4.5 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
1.1 | 3.3 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
1.1 | 6.5 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
1.0 | 3.1 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) corticotropin-releasing hormone receptor activity(GO:0043404) |
1.0 | 4.0 | GO:0070976 | TIR domain binding(GO:0070976) |
1.0 | 3.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
1.0 | 4.8 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.9 | 2.8 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
0.9 | 2.8 | GO:2001069 | glycogen binding(GO:2001069) |
0.9 | 3.7 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.9 | 2.7 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
0.9 | 2.7 | GO:0001565 | phorbol ester receptor activity(GO:0001565) non-kinase phorbol ester receptor activity(GO:0001566) |
0.9 | 2.6 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.9 | 0.9 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
0.9 | 5.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.9 | 4.3 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.8 | 6.7 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.8 | 2.5 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.8 | 2.4 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
0.8 | 3.2 | GO:0004092 | carnitine O-acetyltransferase activity(GO:0004092) |
0.8 | 3.2 | GO:0004921 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
0.8 | 8.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.8 | 2.3 | GO:0004658 | propionyl-CoA carboxylase activity(GO:0004658) |
0.8 | 2.3 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.8 | 3.1 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.8 | 3.0 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.8 | 5.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.8 | 3.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.8 | 3.0 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.7 | 8.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.7 | 19.5 | GO:0031489 | myosin V binding(GO:0031489) |
0.7 | 2.2 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.7 | 4.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.7 | 4.3 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.7 | 7.8 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.7 | 2.0 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
0.7 | 4.7 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.6 | 5.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.6 | 3.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.6 | 1.8 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.6 | 5.5 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.6 | 4.8 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.6 | 1.2 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.6 | 1.8 | GO:0016824 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
0.6 | 3.5 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.6 | 1.7 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.6 | 0.6 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.6 | 1.7 | GO:0003680 | AT DNA binding(GO:0003680) |
0.6 | 2.8 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.6 | 1.7 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.6 | 5.5 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.5 | 4.9 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.5 | 1.6 | GO:0030116 | glial cell-derived neurotrophic factor receptor binding(GO:0030116) |
0.5 | 3.8 | GO:0015099 | nickel cation transmembrane transporter activity(GO:0015099) |
0.5 | 2.7 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.5 | 1.6 | GO:0071077 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
0.5 | 3.7 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.5 | 1.6 | GO:0090556 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.5 | 2.6 | GO:0032810 | sterol response element binding(GO:0032810) |
0.5 | 2.6 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.5 | 2.6 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.5 | 2.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.5 | 2.6 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.5 | 2.0 | GO:2001070 | starch binding(GO:2001070) |
0.5 | 2.0 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
0.5 | 2.0 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.5 | 1.5 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.5 | 1.0 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
0.5 | 2.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.5 | 6.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.5 | 1.5 | GO:0004454 | ketohexokinase activity(GO:0004454) |
0.5 | 1.5 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.5 | 1.5 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.5 | 1.5 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.5 | 1.9 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.5 | 4.8 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.5 | 1.0 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.5 | 3.8 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.5 | 3.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.5 | 4.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.5 | 0.9 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.5 | 2.4 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.5 | 1.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.5 | 9.7 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.5 | 6.4 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.5 | 3.2 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.5 | 3.2 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.4 | 2.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.4 | 1.3 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.4 | 0.9 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.4 | 1.8 | GO:1904121 | propanoyl-CoA C-acyltransferase activity(GO:0033814) propionyl-CoA C2-trimethyltridecanoyltransferase activity(GO:0050632) phosphatidylethanolamine transporter activity(GO:1904121) |
0.4 | 2.6 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.4 | 1.7 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) |
0.4 | 2.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.4 | 0.9 | GO:0051379 | epinephrine binding(GO:0051379) |
0.4 | 1.3 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.4 | 3.0 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.4 | 1.3 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.4 | 1.2 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.4 | 5.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.4 | 3.7 | GO:0031419 | cobalamin binding(GO:0031419) |
0.4 | 2.9 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.4 | 2.5 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.4 | 3.3 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.4 | 2.0 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.4 | 2.4 | GO:0097001 | ceramide binding(GO:0097001) |
0.4 | 3.2 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.4 | 2.7 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.4 | 2.7 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.4 | 6.9 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.4 | 1.5 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.4 | 0.4 | GO:0008199 | ferric iron binding(GO:0008199) |
0.4 | 1.9 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.4 | 1.5 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.4 | 1.5 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.4 | 0.7 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.4 | 0.4 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.4 | 7.3 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.4 | 5.1 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.4 | 1.5 | GO:0004103 | choline kinase activity(GO:0004103) |
0.4 | 4.0 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.4 | 1.1 | GO:0019002 | GMP binding(GO:0019002) |
0.4 | 2.9 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.4 | 1.1 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.4 | 0.7 | GO:0015925 | galactosidase activity(GO:0015925) |
0.4 | 0.4 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.4 | 7.5 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.4 | 2.8 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.4 | 1.1 | GO:0047936 | glucose 1-dehydrogenase [NAD(P)] activity(GO:0047936) |
0.4 | 7.4 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.3 | 0.7 | GO:0043532 | angiostatin binding(GO:0043532) |
0.3 | 0.3 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.3 | 0.3 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.3 | 5.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 1.0 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
0.3 | 2.1 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.3 | 1.7 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.3 | 1.7 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.3 | 0.7 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.3 | 1.4 | GO:0004008 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
0.3 | 6.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.3 | 2.0 | GO:0034618 | arginine binding(GO:0034618) |
0.3 | 19.3 | GO:0019003 | GDP binding(GO:0019003) |
0.3 | 1.0 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
0.3 | 3.0 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.3 | 2.0 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.3 | 1.3 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.3 | 1.3 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
0.3 | 1.0 | GO:0098809 | nitrite reductase activity(GO:0098809) |
0.3 | 0.3 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.3 | 0.3 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.3 | 0.3 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.3 | 0.6 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.3 | 0.9 | GO:0045159 | myosin II binding(GO:0045159) |
0.3 | 1.6 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.3 | 1.2 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.3 | 1.9 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.3 | 0.9 | GO:0004903 | growth hormone receptor activity(GO:0004903) |
0.3 | 1.8 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.3 | 0.3 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.3 | 13.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.3 | 2.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.3 | 0.9 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.3 | 0.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.3 | 1.8 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.3 | 1.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.3 | 1.2 | GO:0042806 | fucose binding(GO:0042806) |
0.3 | 1.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.3 | 1.8 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.3 | 0.9 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.3 | 0.9 | GO:0004335 | galactokinase activity(GO:0004335) |
0.3 | 0.3 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.3 | 3.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.3 | 2.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.3 | 0.9 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.3 | 1.1 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.3 | 1.1 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.3 | 0.9 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.3 | 2.8 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.3 | 2.3 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.3 | 1.1 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.3 | 0.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.3 | 1.7 | GO:0000298 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.3 | 0.8 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.3 | 1.4 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.3 | 1.4 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.3 | 0.8 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.3 | 1.7 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.3 | 2.8 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.3 | 1.1 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.3 | 0.5 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.3 | 0.8 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
0.3 | 1.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.3 | 1.6 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.3 | 1.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 1.1 | GO:0050436 | microfibril binding(GO:0050436) |
0.3 | 0.8 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.3 | 4.0 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.3 | 0.8 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.3 | 1.3 | GO:0038132 | neuregulin binding(GO:0038132) |
0.3 | 3.7 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.3 | 1.9 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.3 | 0.8 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.3 | 1.0 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 1.0 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
0.3 | 0.8 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.3 | 4.2 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.3 | 1.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.3 | 8.0 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.3 | 1.0 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.3 | 0.8 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.3 | 3.8 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.3 | 2.5 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.3 | 1.8 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.3 | 12.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.3 | 2.8 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 0.5 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.2 | 1.0 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.2 | 1.2 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.2 | 0.5 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.2 | 1.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 1.7 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 1.0 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.2 | 0.7 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.2 | 7.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 1.7 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 1.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 3.3 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 1.4 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.2 | 0.9 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 0.2 | GO:0048185 | activin binding(GO:0048185) |
0.2 | 0.9 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.2 | 1.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 0.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.2 | 0.9 | GO:0019808 | polyamine binding(GO:0019808) |
0.2 | 0.7 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.2 | 0.7 | GO:0031208 | POZ domain binding(GO:0031208) |
0.2 | 0.7 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.2 | 0.7 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.2 | 1.1 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.2 | 0.9 | GO:0015232 | heme transporter activity(GO:0015232) |
0.2 | 1.6 | GO:0000150 | recombinase activity(GO:0000150) |
0.2 | 0.7 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.2 | 2.7 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 1.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 4.0 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.2 | 0.9 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.2 | 0.9 | GO:0008941 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
0.2 | 3.7 | GO:1905030 | voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.2 | 0.9 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 1.7 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 4.7 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 2.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 0.8 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) |
0.2 | 0.4 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.2 | 5.9 | GO:0001968 | fibronectin binding(GO:0001968) |
0.2 | 0.4 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.2 | 2.5 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 7.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 0.6 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 5.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 3.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 1.0 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.2 | 0.8 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
0.2 | 0.4 | GO:0038100 | nodal binding(GO:0038100) |
0.2 | 3.4 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 4.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 1.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 2.8 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 0.4 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.2 | 0.6 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.2 | 3.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 0.6 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.2 | 0.6 | GO:0072541 | peroxynitrite reductase activity(GO:0072541) |
0.2 | 2.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 2.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 1.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 0.6 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.2 | 2.5 | GO:0050308 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
0.2 | 2.7 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 0.6 | GO:0005550 | pheromone binding(GO:0005550) |
0.2 | 1.7 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.2 | 3.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 0.2 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.2 | 0.6 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.2 | 0.9 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 0.7 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 0.7 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.2 | 1.8 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 2.3 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.2 | 0.5 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 0.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 0.5 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.2 | 0.7 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.2 | 3.7 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.2 | 3.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 0.2 | GO:0070401 | NADP+ binding(GO:0070401) |
0.2 | 2.9 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.2 | 4.7 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 1.0 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 0.3 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.2 | 0.5 | GO:0070737 | protein-glycine ligase activity, elongating(GO:0070737) |
0.2 | 4.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 0.7 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.2 | 0.7 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.2 | 0.5 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
0.2 | 1.9 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 0.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.2 | 0.7 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.2 | 3.0 | GO:0048038 | quinone binding(GO:0048038) |
0.2 | 2.3 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.2 | 5.3 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.2 | 4.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 0.5 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.2 | 0.8 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.2 | 0.5 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 0.5 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
0.2 | 0.8 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.2 | 1.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 1.0 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.2 | 0.3 | GO:0002046 | opsin binding(GO:0002046) |
0.2 | 4.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 0.3 | GO:0005534 | galactose binding(GO:0005534) |
0.2 | 0.8 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.2 | 0.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 1.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.2 | 0.5 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.2 | 2.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 0.9 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 1.4 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.2 | 0.6 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.2 | 0.6 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 1.2 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.2 | 1.7 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 1.4 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 0.5 | GO:0002054 | nucleobase binding(GO:0002054) |
0.1 | 1.8 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.4 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.4 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 0.6 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.1 | 4.4 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 1.0 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.6 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 0.7 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 2.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 4.9 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 1.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 3.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 1.0 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 2.7 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.7 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.8 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 2.8 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.4 | GO:0030984 | kininogen binding(GO:0030984) |
0.1 | 0.4 | GO:0033265 | choline binding(GO:0033265) |
0.1 | 0.6 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 1.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.4 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.4 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.1 | 1.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.5 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.1 | 1.2 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 1.8 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.8 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 0.8 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 0.5 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 1.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 17.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 4.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.7 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.1 | 0.4 | GO:0071568 | UFM1 transferase activity(GO:0071568) |
0.1 | 1.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.4 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.1 | 1.2 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 0.6 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.8 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.8 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.8 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 0.4 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.1 | 3.9 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 0.9 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 3.5 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 3.0 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 0.5 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.1 | 3.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 1.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 2.0 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.4 | GO:0033699 | DNA 5'-adenosine monophosphate hydrolase activity(GO:0033699) |
0.1 | 1.0 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.7 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.7 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.5 | GO:0035877 | death effector domain binding(GO:0035877) |
0.1 | 2.4 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 1.9 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.6 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 0.1 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
0.1 | 0.7 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 1.4 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 1.4 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 18.4 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.6 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.1 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 3.2 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.1 | 7.2 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.3 | GO:0030977 | taurine binding(GO:0030977) |
0.1 | 0.7 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.1 | 10.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.5 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.5 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
0.1 | 1.6 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.9 | GO:0005272 | sodium channel activity(GO:0005272) |
0.1 | 0.4 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 1.4 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.1 | 4.1 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.5 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.9 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.1 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.1 | 0.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 4.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.7 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 0.3 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 1.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 1.3 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 2.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.5 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.2 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 0.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.9 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.8 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.1 | 0.4 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.1 | 3.2 | GO:0019905 | syntaxin binding(GO:0019905) |
0.1 | 0.8 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.6 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 0.8 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.7 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 0.4 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.4 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.1 | 4.3 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.9 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 1.7 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 0.9 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.7 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.7 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.5 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.3 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.3 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 5.0 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 1.0 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 1.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.4 | GO:0055100 | adiponectin binding(GO:0055100) |
0.1 | 0.4 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 1.8 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 4.1 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 0.3 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
0.1 | 0.2 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.1 | 2.2 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 1.0 | GO:0015250 | water channel activity(GO:0015250) |
0.1 | 1.2 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 1.0 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.9 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 0.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 0.6 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.1 | 0.6 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 2.1 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 1.7 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.1 | GO:0019981 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.1 | 0.9 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 3.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.7 | GO:0016918 | retinal binding(GO:0016918) |
0.1 | 0.2 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.1 | 0.2 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.1 | 1.5 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 10.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 4.5 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 0.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 0.3 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 0.6 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 1.6 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.3 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.1 | 0.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 0.7 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 3.0 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.6 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.1 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.1 | 0.8 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 3.9 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.1 | 0.2 | GO:0015229 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.1 | 0.3 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.1 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.9 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.1 | GO:0004096 | catalase activity(GO:0004096) |
0.1 | 0.9 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 0.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 1.0 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.1 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 17.2 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 1.1 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.2 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 2.6 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 0.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.4 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 1.0 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 4.0 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 0.2 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
0.1 | 2.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.4 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 1.2 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.1 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 1.6 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 0.2 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) |
0.1 | 0.8 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.8 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.3 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.1 | 3.4 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 1.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 0.4 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 0.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.2 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.0 | 0.6 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.2 | GO:0086038 | calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086038) |
0.0 | 2.7 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.0 | 0.0 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.0 | 0.1 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
0.0 | 0.1 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.0 | 0.8 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.3 | GO:0005536 | glucose binding(GO:0005536) |
0.0 | 0.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.0 | 1.3 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 5.7 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.2 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.0 | 0.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.1 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.0 | 0.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.1 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.0 | 0.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 1.6 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.0 | 0.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.0 | 0.6 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.0 | 0.2 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.2 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.4 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.0 | 0.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.0 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.1 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
0.0 | 0.1 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
0.0 | 0.5 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.0 | 0.2 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.0 | 0.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.1 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.0 | 0.2 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 0.5 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 3.6 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.7 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 1.2 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 0.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.3 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.1 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.0 | 0.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.0 | 0.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.5 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.0 | 0.1 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.0 | 0.9 | GO:0019955 | cytokine binding(GO:0019955) |
0.0 | 0.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.2 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.0 | 0.1 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.0 | 0.4 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.0 | 0.8 | GO:0046906 | tetrapyrrole binding(GO:0046906) |
0.0 | 0.0 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.0 | 0.1 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.0 | 0.1 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 0.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.1 | GO:0022840 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.0 | 0.1 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.0 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.0 | 0.0 | GO:0043176 | amine binding(GO:0043176) |
0.0 | 0.0 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 11.3 | ST STAT3 PATHWAY | STAT3 Pathway |
0.4 | 18.0 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.4 | 0.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.4 | 1.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.3 | 0.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 2.7 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.3 | 2.6 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.3 | 3.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 0.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.3 | 1.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.3 | 1.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 7.4 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.3 | 0.3 | PID IFNG PATHWAY | IFN-gamma pathway |
0.3 | 0.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 5.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 0.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 4.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 6.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 11.9 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 1.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 2.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 4.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 11.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 9.6 | PID ENDOTHELIN PATHWAY | Endothelins |
0.2 | 7.0 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 4.6 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.2 | 19.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 3.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 7.5 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 4.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 0.6 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 10.1 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 11.9 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.2 | 2.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 13.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 1.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 2.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 1.4 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 4.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 2.7 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.2 | 2.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 1.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 0.9 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 9.0 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.2 | 5.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 3.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 5.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 8.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 7.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 1.0 | ST GAQ PATHWAY | G alpha q Pathway |
0.2 | 3.9 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 6.2 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 2.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 5.1 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 0.9 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 3.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 2.5 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 1.6 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 3.8 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 3.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 6.3 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 0.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 0.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 3.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 21.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 14.1 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 0.9 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 3.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 1.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 2.6 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 2.0 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 1.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 18.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.9 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 1.6 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 1.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 1.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 4.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 0.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 0.8 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 3.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 13.5 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 2.1 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 1.5 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 8.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 2.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.4 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.8 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.3 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.3 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 1.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.9 | 21.6 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.8 | 1.6 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.7 | 2.1 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.7 | 7.5 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.7 | 13.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.6 | 5.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.6 | 2.8 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.6 | 4.5 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.5 | 21.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.5 | 1.6 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
0.5 | 4.3 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.5 | 5.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.4 | 0.9 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.4 | 4.4 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.4 | 0.4 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.4 | 11.5 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.4 | 7.7 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.3 | 0.3 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.3 | 18.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.3 | 4.3 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.3 | 3.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 1.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.3 | 17.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.3 | 10.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.3 | 3.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.3 | 3.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.3 | 14.1 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.3 | 2.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.3 | 4.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.3 | 8.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.3 | 5.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.3 | 10.1 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.3 | 3.7 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.3 | 0.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.3 | 6.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.3 | 4.9 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.3 | 2.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.3 | 4.8 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 0.7 | REACTOME KINESINS | Genes involved in Kinesins |
0.2 | 2.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 1.7 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.2 | 2.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 6.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 1.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.2 | 4.8 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 2.9 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.2 | 7.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 4.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.2 | 5.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 4.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 3.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 6.1 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.2 | 0.2 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.2 | 0.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 1.9 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.2 | 2.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.2 | 9.1 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 7.7 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.2 | 5.0 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 3.2 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.2 | 3.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 2.7 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.2 | 2.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.2 | 0.5 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 3.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 2.3 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.2 | 1.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 1.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 1.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 4.5 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 0.2 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 1.2 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 13.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 1.2 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 1.6 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 6.5 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 1.7 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 1.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 2.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 1.1 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.4 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 2.2 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 1.9 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 4.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 2.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 1.4 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 3.0 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 5.8 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 4.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 1.9 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.5 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 5.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.7 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 2.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.8 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.1 | 0.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 2.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.0 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.1 | 7.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 1.9 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 1.0 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 2.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 0.5 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.1 | 1.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 2.5 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 0.6 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 1.0 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 3.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 0.6 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 2.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 0.1 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.1 | 0.9 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 0.7 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 3.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 11.1 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 1.4 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 0.7 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 2.0 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 2.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.1 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 0.9 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 2.8 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 1.4 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.1 | 0.1 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.1 | 1.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 0.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 1.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 0.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 0.7 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 0.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 1.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 0.1 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 1.4 | REACTOME PI3K EVENTS IN ERBB2 SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
0.0 | 0.9 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.7 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.2 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 11.2 | REACTOME GPCR DOWNSTREAM SIGNALING | Genes involved in GPCR downstream signaling |
0.0 | 0.4 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.9 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.0 | 0.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.1 | REACTOME PLATELET ACTIVATION SIGNALING AND AGGREGATION | Genes involved in Platelet activation, signaling and aggregation |
0.0 | 0.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 3.3 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.3 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.0 | 1.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 1.4 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |